Subsequent Events [Table]
Subsequent Events [Table]
Subsequent Events [Table]
Unrecognized equity method losses
Unrecognised share of losses of associates
Disclosure of weighted average exercise prices for options outstanding
Disclosure of Weighted Average Exercise Prices for Options Outstanding [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Outstanding
Income taxes, net
Adjustments for income tax expense
Subsidiary notes payable
Subsidiary Notes Payable [Member]
Subsidiary Notes Payable
Merger reserve
Merger reserve [member]
Investments held at fair value
Beginning balance
Ending balance
Non-current financial assets at fair value through profit or loss
Not impaired [Line Items]
Not impaired [Line Items]
Not impaired
Gains (losses) on financial assets at fair value through profit or loss
Gains (losses) on financial assets at fair value through profit or loss
RSU
Restricted Share Units (RSU) [Member]
Restricted Share Units (RSU) [Member]
Loss with respect to associate for which no deferred tax asset is recognized
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Rate of loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Subsidiary operating companies
Subsidiary operating companies [Abstract]
Subsidiary operating companies
Fair value gain on other financial instruments
Adjustments for gains (losses) on change in fair value of derivatives
Operating segments
Operating segments [member]
Income Tax Type [Axis]
Income Tax Type [Axis]
Income Tax Type
Treasury stock
Treasury shares
Levels of fair value hierarchy [axis]
Levels of fair value hierarchy [axis]
0.01
Exercise Price Range One [Member]
Exercise Price Range One [Member]
Research and development expenses
Research and development expenses
Research and development expenses
Research and development expense
Gain/(loss) from change in fair value of convertible debt
Gain/(Loss) from change in fair value of convertible debt
Gain/(Loss) from change in fair value of convertible debt
Purchases of intangible assets
Purchase of intangible assets, classified as investing activities
Acquisition of equity instruments in other entities, discount rate
Acquisition of Equity Instruments In Other Entities, Discount Rate
Acquisition of Equity Instruments In Other Entities, Discount Rate
Executive Compensation
Executive compensation, reconciliation of effective tax rate
Executive compensation, reconciliation of effective tax rate
Tax Effected
Tax Effected [Member]
Tax Effected
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]
Cash flows from investing activities:
Cash flows from (used in) investing activities [abstract]
Within Three Months
Within Three Months [Member]
Within Three Months
Non-controlled founded entities
Non-Controlled Founded Entities [Member]
Non-Controlled Founded Entities
Deferred tax assets
Deferred tax assets
Taxation
Disclosure of income tax [text block]
Entrega and Vedanta
Entrega and Vedanta [Member]
Entrega and Vedanta
Minimum liquidation preference
Minimum liquidation preference
Minimum liquidation preference
Property and equipment, net
Balance at beginning of period
Balance at end of period
Property, plant and equipment
Geographical areas [member]
Geographical areas [member]
Final fee, percentage of original principal amount outstanding
Debt instrument, payment terms, final fee, percentage of original principal amount outstanding
Debt instrument, payment terms, final fee, percentage of original principal amount outstanding
Weighted average grant date fair value, RSU vested (in GBP per share)
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Weighted average grant date fair value of other equity instruments Vested in share-based payment arrangement
Subsequent Events [Line Items]
Subsequent Events [Line Items]
Subsequent Events
Disclosure of share capital, reserves and other equity interest [Abstract]
Disclosure of share capital, reserves and other equity interest [Abstract]
Other
Other tax effects for reconciliation between accounting profit and tax expense (income)
Related parties
Related parties [member]
Options exercisable (in shares)
Number of options (in shares)
Number of share options exercisable in share-based payment arrangement
Document and Entity Information [Line Items]
Document Information [Line Items]
Other not including Vedanta
Other not including Vedanta [Member]
Other not including Vedanta
Related party transactions [abstract]
Related party transactions [abstract]
Proceeds from the issuance of shares and subsidiary preferred shares
Proceeds from issuing shares
Share-based payment expense
Expense from share-based payment transactions with parties other than employees
Subsidiaries with material non-controlling interests
Subsidiaries with material non-controlling interests [member]
General and administrative
General And Administrative [Member]
General And Administrative
Classes of share capital [axis]
Classes of share capital [axis]
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC [Line Items]
Equity - Acquired Share capital PureTech LLC
Ensof Holdings, LLC (held indirectly through Enlight)
Ensof Holdings LLC [Member]
Ensof Holdings LLC
Share-based compensation arrangement by share-based payment award, award vesting period
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period
Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period
Investment, Name [Domain]
Investment, Name [Domain]
2018 performance based RSU
2018 Performance Based RSU [Member]
2018 Performance Based RSU
Weighted Average Options exercisable [Table]
Weighted Average Options exercisable [Table]
Weighted Average Options exercisable [Table]
Percentage of voting equity interests acquired
Percentage of voting equity interests acquired
Other Financial Assets [Abstract]
Other Financial Assets [Abstract]
Lease liability, number of renewal options
Lease Liability, Number Of Renewal Options
Lease Liability, Number Of Renewal Options
Disclosure of financial liabilities [line items]
Disclosure of financial liabilities [line items]
Disclosure of long-term loan - Vedanta
Disclosure of borrowing costs [text block]
Recognition of deferred tax assets and tax benefits not previously recognized
Tax Rate Effect of deferred tax assets and benefits not previously recognised
Tax Rate Effect of deferred tax assets and benefits not previously recognised
R&D and orphan drug tax credits
Rate of Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Rate of Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Expiring [Domain]
Expiring [Domain]
Expiring [Domain]
Segments
Segments [member]
Grant Income
Description of accounting policy for government grants [text block]
Total current assets
Current assets
Current assets
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Tax losses and tax credits carryforwards [Line Items]
Group's share of total comprehensive loss - limited to net investment amount
Share of total comprehensive income of associates and joint ventures accounted for using equity method
Number of shares issuable based on performance conditions
Number of shares issuable based on performance conditions
Number of shares issuable based on performance conditions
Entity Address, State or Province
Entity Address, State or Province
Directors and Senior Managers
Directors and Senior Managers [Member]
Directors and Senior Managers
Loss from continuing operations (100%)
Profit (loss) from continuing operations
Shares issued (in shares)
Increase Decrease In Number Of Shares Outstanding, Changes In Ownership Interest In Subsidiaries That Do Not Result In Loss Of Control
Increase Decrease In Number Of Shares Outstanding, Changes In Ownership Interest In Subsidiaries That Do Not Result In Loss Of Control
Loss with respect to associate for which no deferred tax asset is recognized
Loss with respect to associate for which no deferred tax asset is recognized , reconciliation of effective tax rate
Loss with respect to associate for which no deferred tax asset is recognized, reconciliation of effective tax rate
Geographical areas [axis]
Geographical areas [axis]
Disclosure of tax balances as presented in statement of financial position
Disclosure of tax balances as presented in Statement of Financial Position [Table Text Block]
Disclosure of tax balances as presented in Statement of Financial Position
Disclosure of auditors' remuneration
Disclosure of auditors' remuneration [text block]
Lease receivable – long-term
Long-term Portion of Lease Receivable
Non-current finance lease receivables
Other
Other, non-controlling interest, equity
Other, non-controlling interest, equity
Basis of Presentation
Description Of Accounting Policy For Basis Of Presentation [Policy Text Block]
Description Of Accounting Policy For Basis Of Presentation
Disclosure of financial assets [line items]
Disclosure of financial assets [line items]
Disclosure of detailed information about property, plant and equipment
Disclosure of detailed information about property, plant and equipment [text block]
Trade and other receivables
Trade receivables [member]
Gelesis, Inc.
Gelesis
Gelesis [Member]
Gelesis
Sonde Deconsolidation
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Rate of deconsolidation adjustments, reconciliation of effective tax rate
Short-term note [Line Items]
Short-term note [Line Items]
Short-term note [Line Items]
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares [Line Items]
Changes in the value of subsidiary preferred shares
Foreign Currency
Description of accounting policy for foreign currency translation [text block]
Long-term loan
Non-current portion of non-current borrowings
Total non-current assets
Non-current assets
Non-current assets
Disclosure of detailed information about intangible assets [table]
Disclosure of detailed information about intangible assets [table]
Other Financial Assets
Disclosure of other assets [text block]
Interest Expense
Rate of interest expense, reconciliation of effective tax rate
Rate of interest expense, reconciliation of effective tax rate
Disclosure of detailed information about intangible assets [abstract]
Disclosure of changes in financial liabilities - warrants
Disclosure of financial liabilities - Warrants [Table Text Block]
Disclosure of financial liabilities - Warrants
Grant date fair value
Weighted average fair value at measurement date, share options granted
Tenant improvement - lease incentive
Tenant improvements, Right of use Assets
Tenant improvements, Right of use Assets
Minimum liquidation preference [Line Items]
Minimum liquidation preference [Line Items]
Minimum liquidation preference
Non-cash items:
Non-cash items [Abstract]
Non-cash items
Equity Instruments Issued by the Group
Description of accounting policy for equity instruments issued by the group [Policy Text Block]
Description of accounting policy for equity instruments issued by the group
Derivative financial assets
Derivative financial assets
Purchase of Treasury stock (in shares)
Purchase of treasury stock (in shares)
Number Of Treasury Shares Purchased
Number Of Treasury Shares Purchased
Purchases of Convertible Note
Purchases of Convertible Note
Purchases of Convertible Note
Series A-2 preferred
Series A-2 Preferred [Member]
Series A-2 Preferred [Member]
Capital And Financial Risk Management Credit Risk [Abstract]
Capital And Financial Risk Management [Abstract]
Disclosure of weighted average exercise prices for options exercised
Disclosure of Weighted Average Exercise Prices for Options Exercised [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Exercised
Audit of these financial statements
Auditor's remuneration for audit services
Financial assets, class
Financial assets, class [member]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Subsidiaries
Description of accounting policy for subsidiaries [text block]
Current year losses for which no deferred tax asset is recognized
Tax effect of tax losses
Document Type
Document Type
Statement Of Cash Flows [Line Items]
Statement Of Cash Flows [Line Items]
Statement Of Cash Flows [Line Items]
Exchange of Gelesis preferred shares to Gelesis common shares
Financial Investments, Gain (Loss) On Exchange Of Preferred Stock To Common Stock Through Profit Or Loss
Financial Investments, Gain (Loss) On Exchange Of Preferred Stock To Common Stock Through Profit Or Loss
Customer B
Customer B [Member]
Customer B
Revenue [abstract]
Revenue [abstract]
Note from associate
Non-current receivables due from associates
US federal statutory rate
Applicable tax rate
Aggregate payroll costs
Total payroll costs
Payroll Costs
Payroll Costs
Average number of employees
Average number of employees
Royalty Pharma
Royalty Pharma [Member]
Royalty Pharma
Tax Credits
Tax credits expiring
Unused tax credits for which no deferred tax asset recognised
Deconsolidation
Current Financial Liabilities, Decrease Due To Deconsolidation
Current Financial Liabilities, Decrease Due To Deconsolidation
Furniture and fixtures
Fixtures and fittings [member]
Finance Income and Finance Costs
Description of accounting policy for finance income and costs [text block]
Depreciation
Depreciation, property, plant and equipment
Share Capital
Description of accounting policy for issued capital [text block]
Rentable area (in square feet)
Lease Liability, Rentable Area
Lease Liability, Rentable Area
Cash in deconsolidated subsidiary
Cash
Net cash used in operating activities
Cash flows from (used in) operating activities
Equity attributable to the owners of the Company
Equity attributable to owners of parent
Loss on disposal of assets
Adjustments for gain (loss) on disposals, property, plant and equipment
Share-based Payments
Description of accounting policy for share-based payment transactions [text block]
Segment Information [Abstract]
Segment Information [Abstract]
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries [Table]
Accounting Policies - Subsidiaries
Disclosure of range of exercise prices of outstanding share options [table]
Disclosure of range of exercise prices of outstanding share options [table]
Forfeited (in shares)
Number of share options forfeited (in shares)
Number of share options forfeited in share-based payment arrangement
Settlement of restricted stock unit equity awards
Settlement of RSU's
Settlement of RSU's
Interest received
Interest received, classified as operating activities
Commitments and Contingencies
Disclosure of commitments and contingent liabilities [text block]
Revaluation of deferred tax assets related to share-based awards
Increase (Decrease) Through Revaluation Of Deferred Tax Assets Related To Share-based Payment Transactions, Equity
Increase (Decrease) Through Revaluation Of Deferred Tax Assets Related To Share-based Payment Transactions, Equity
Financial Instruments - Warrants [Abstract]
Financial Instruments - Warrants [Abstract]
Financial Instruments - Warrants
Interest paid
Borrowings, Interest paid
Borrowings, Interest paid
Potential securities excluded from diluted EPS calculation (in shares)
Potential securities excluded from diluted EPS calculation
Potential securities excluded from diluted EPS calculation
Commense Inc.
Commense [Member]
Commense
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense [Line Items]
Recognised Income Tax Expense
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, assets
Ownership percentage of associate's equity
Ownership Percentage Of Associate's Equity
Ownership Percentage Of Associate's Equity
Other
Other current payables
No Trading Symbol Flag
No Trading Symbol Flag
Impairment of financial assets [axis]
Impairment of financial assets [axis]
Operating Expense Category [Domain]
Operating Expense Category [Domain]
Operating Expense Category [Domain]
Subsidiary operating companies
Subsidiary Operating Companies [Member]
Subsidiary Operating Companies
Disclosure of significant unobservable inputs used in fair value measurement of assets [table]
Disclosure of significant unobservable inputs used in fair value measurement of assets [table]
Customer A
Customer A [Member]
Customer A
Acquisition of subsidiary non-controlling interest
Increase (decrease) through acquisition of subsidiary, equity
Disclosure of deferred taxes
Disclosure of deferred taxes [text block]
Subsidiary convertible notes
Subsidiary Convertible Notes [Member]
Subsidiary Convertible Notes
RSU [Line Items]
RSU [Line Items]
RSU
Lease liability, non-current
Long-term Portion of Lease Liability
Non-current lease liabilities
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Three to Twelve months
Later than three months and not later than one year [member]
Earnings Category [Domain]
Earnings Category [Domain]
Earnings Category [Domain]
Disclosure of earnings/(loss) per share
Schedule of Earnings per Share [Table Text Block]
Schedule of Earnings per Share
Current receivables due from related parties
Current receivables due from related parties
Disclosure of lease liabilities
Disclosure of Lease Liabilities [Table Text Block]
Disclosure of Lease Liabilities
Dr Raju Kucherlapati
Dr Raju Kucherlapati [Member]
Dr Raju Kucherlapati
Entity Registrant Name
Entity Registrant Name
Deconsolidation
Deconsolidation
Deconsolidation
Deconsolidation
Karuna and Vor
Karuna And Vor [Member]
Karuna And Vor
Disclosure of disaggregation of revenue from contracts with customers [table]
Disclosure of disaggregation of revenue from contracts with customers [table]
Effects of state tax rate in U.S.
Rate of Effects of state tax rate in US
Rate of Effects of state tax rate in US
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Unrecognized deferred tax assets [Table]
Subsequent Events [Abstract]
Subsequent Events [Abstract]
Deconsolidated former subsidiary operating companies
Deconsolidated former subsidiaries [Abstract]
Deconsolidated former subsidiaries
Issuance of convertible note receivable
Issuance Of Convertible Note Receivable [Member]
Issuance Of Convertible Note Receivable
Group's share of net assets (net deficit)
Share of net assets
Share of net assets
PureTech Health (Company)
PureTech Health (Company) [Member]
PureTech Health (Company)
Minimum
Minimum [Member]
Entity Emerging Growth Company
Entity Emerging Growth Company
Inactive subsidiaries
Inactive subsidiaries [Abstract]
Inactive subsidiaries
Acquired minority non-controlling interest
Acquired minority non-controlling interest
Acquired minority non-controlling interest
Investment, Name [Axis]
Investment, Name [Axis]
Trading Symbol
Trading Symbol
Entity File Number
Entity File Number
Decrease through loss of control of subsidiary, net assets
Decrease Through Loss Of Control Of Subsidiary, Net Assets
Decrease Through Loss Of Control Of Subsidiary, Net Assets
Imbrium Therapeutics L.P.
Imbrium Therapeutics L.P. [Member]
Imbrium Therapeutics L.P.
Floating interest rate
Floating interest rate [member]
Volatility
Historical volatility for shares, measurement input [member]
Disclosure of operating segments [table]
Disclosure of operating segments [table]
Other income/(expense)
Other income/(expense)
Other gains (losses)
Number of options held (in shares)
Number of Options held
Number of Options held
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Subsidiary Preferred Shares [Abstract]
Share-based Payments Table [Line Items]
Share-based Payments Table [Line Items]
Share-based Payments Table
Remuneration expense
Directors' remuneration expense
Unrealized gain (loss) – change in fair value through profit and loss
Loss – change in fair value through profit and loss
Increase (decrease) in fair value measurement, assets
Subsidiary preferred shares
Subsidiary Preferred Shares [Member]
Subsidiary Preferred Shares
Operating tax losses
Unused tax losses [member]
Types of financial assets [axis]
Types of financial assets [axis]
Summary of investments held at fair value
Summary Of investments held at fair value [Table Text Block]
Summary Of investments held at fair value
Total non-current liabilities
Non-current liabilities
Non-current liabilities
More than 10 years
Later than ten years [member]
Disclosure of detailed information about property, plant and equipment [abstract]
Risk-free interest rate
Risk free interest rate, share options granted
Conversion of subsidiary convertible note into preferred share liabilities
Conversion of subsidiary Convertible note into preferred share liabilities
Conversion of subsidiary Convertible note into preferred share liabilities
Proportion of ownership interest in subsidiary
Proportion of ownership interest in subsidiary
Weighted average exercise price of, options exercisable (in GBP per share)
Weighted average exercise price (in dollars per share)
Weighted average exercise price of share options exercisable in share-based payment arrangement
Proceeds from sale of equity investment
Proceeds From Sale Of Equity Investment
Proceeds From Sale Of Equity Investment
Purchase of investments other than investments accounted for using equity method
Cash Investment (Akili)
Purchase of investments other than investments accounted for using equity method
Weighted average exercise price, options exercised (in GBP per share)
Weighted average exercise price (in dollars per share)
Weighted average exercise price of share options exercised in share-based payment arrangement
Weighted average stock price of share options exercised in share-based payment arrangement (in GBP per share)
Weighted average stock price of share options exercised in share-based payment arrangement
Weighted average stock price of share options exercised in share-based payment arrangement
Controlled founded entities
Controlled Founded Entities [Member]
Controlled Founded Entities
Disclosure of RSU activity
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Other comprehensive income/(loss):
Other comprehensive income [abstract]
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Changes in the value of subsidiary preferred shares [Table]
Gain on dilution of ownership interest in associate
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate, Without Earn-out Shares
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate, Without Earn-out Shares
Fixed assets
Property, plant and equipment [member]
Effect of treasury shares purchased (in shares)
Dilutive effect of purchase of treasury shares on number of ordinary shares
Dilutive effect of purchase of treasury shares on number of ordinary shares
Disclosure of significant unobservable inputs used in fair value measurement of assets [abstract]
Disclosure of significant unobservable inputs used in fair value measurement of assets [abstract]
Increase (decrease) through conversion of convertible instruments, equity
Increase (decrease) through conversion of convertible instruments, equity
Weighted Average Options forfeited [Line Items]
Weighted Average Options forfeited [Line Items]
Weighted Average Options forfeited
Lighthouse Capital Partners VI, L.P
Lighthouse Capital Partners VI, L.P [Member]
Lighthouse Capital Partners VI, L.P
Revenue
Disclosure of revenue [text block]
Disclosure of detailed information about borrowings [abstract]
Disclosure of detailed information about borrowings [abstract]
Conversion of convertible notes into preferred shares - non cash financing activity
Conversion of convertible notes
Conversion of convertible notes
Subsidiary Preferred Shares
Disclosure of Subsidiary Preferred Shares [Text Block]
Disclosure of Subsidiary Preferred Shares
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Non-Controlling Interests [Abstract]
Granted (in shares)
Number of other equity instruments granted in share-based payment arrangement
Contract revenue
Revenue from contracts with customers
Deconsolidation of subsidiaries
Decrease through loss of control of subsidiary, property, plant and equipment
Share-based payment arrangement after tax deduction, cash used to settle award
Share-based Payment Settlement, cash received by employee after tax withheld on employee's behalf
Share-based Payment Settlement, cash received by employee after tax withheld on employee's behalf
Entity's total for segment consolidation items
Entity's total for segment consolidation items [member]
Dr Robert Langer
Dr Robert Langer [Member]
Dr Robert Langer
Exercise of stock options
Proceeds from exercise of options
Property, plant and equipment [Table]
Disclosure of detailed information about property, plant and equipment [table]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Subsidiary Preferred Shares [Table]
Jefferies International Limited
Jefferies International Limited [Member]
Jefferies International Limited
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Equity - Acquired Share capital PureTech LLC [Table]
Entity Interactive Data Current
Entity Interactive Data Current
Leases - Rental [Line Items]
Leases - Rental [Line Items]
Leases - Rental [Line Items]
Related Parties Transactions
Disclosure of transactions between related parties [text block]
Depreciation and amortization
Adjustments for depreciation and amortisation expense
Weighted Average Options Outstanding [Abstract]
Weighted Average Options Outstanding [Abstract]
Weighted Average Options Outstanding
Healthcare benefits
Employee benefits expense
Lease Contractual Term [Domain]
Lease Contractual Term [Domain]
Lease Contractual Term [Domain]
Proportion of ownership interests held by non-controlling interests
Proportion of ownership interests held by non-controlling interests
Other general and administrative expenses
Other Selling General and Administrative Expense
Other Selling General and Administrative Expense
Investor
Investor [Member]
Investor
Liability for share based awards
Liabilities from share-based payment transactions
Trade and other receivables
Adjustments for decrease (increase) in trade and other receivables
Performance Share Plan [Abstract]
Performance Share Plan [Abstract]
Performance Share Plan
Owners of the Company
Comprehensive income, attributable to owners of parent
Business Contact
Business Contact [Member]
Balance at beginning of period
Balance at end of period
Financial liabilities, at fair value
Financial liabilities
Financial liabilities, at fair value
Disclosure of financial assets [table]
Disclosure of financial assets [table]
Change in blended state rate impact due to state apportionment change
Tax Rate Effect Of Adjustments Related To Change In Blend State Rate
Tax Rate Effect Of Adjustments Related To Change In Blend State Rate
Share-based payment expense
Share-based payment expense
Expense from share-based payment transactions with employees
Timing of transfer of goods or services [member]
Timing of transfer of goods or services [member]
Exercise of share-based awards (in shares)
Effect of shares issued (in shares)
Increase (decrease) in number of ordinary shares issued
Four to five years
Later than four years and not later than five years [member]
Disclosure of range of exercise prices of outstanding share options [line items]
Disclosure of range of exercise prices of outstanding share options [line items]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
Financial Instruments [Abstract]
US federal statutory rate
Tax expense (income) at applicable tax rate
Operating loss carryforwards not subject to expiration
Operating Loss Carryforwards Not Subject To Expiration [Member]
Operating Loss Carryforwards Not Subject To Expiration
Disclosure of significant unobservable inputs - investments at fair value, assets
Financial Instruments, Significant unobservable Inputs - Investments at Fair Value, Assets [Table Text Block]
Financial Instruments, Significant unobservable Inputs - Investments at Fair Value, Assets
Akili and Gelesis
Akili and Gelesis [Member]
Akili and Gelesis
Amortization of intangible assets
Amortisation expense
Weighted Average number of ordinary shares [Table]
Weighted Average number of ordinary shares [Table]
Weighted Average number of ordinary shares
Purchase of investments held at fair value
Cash purchase of Vor preferred shares
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
Class B common
Class B Common [Member]
Class B Common
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category [Axis]
Share-based Payment Expense Category
Disclosure of long-term loan obligations
Disclosure of long-term loan obligations [Table Text Block]
Disclosure of long-term loan obligations
Disclosure of disaggregation of revenue from contracts with customers
Disclosure of disaggregation of revenue from contracts with customers [text block]
Revenue recognized on deferred revenue outstanding at prior year end
Revenue recognized on deferred revenue outstanding at prior year end
Revenue recognized on deferred revenue outstanding at prior year end
New Standards and Interpretations Not Yet Adopted [Abstract]
New Standards and Interpretations Not Yet Adopted [Abstract]
Deferred revenue
Adjustments for increase decrease In deferred revenue
Adjustments for increase decrease In deferred revenue
Document Fiscal Year Focus
Document Fiscal Year Focus
Disclosure of terms and conditions of share-based payment arrangement
Disclosure of terms and conditions of share-based payment arrangement [text block]
Income taxes paid
Income taxes paid (refund), classified as operating activities
Outside investors
Outside investors [Member]
Outside investors
Acquisition of a non-controlling Interest of a subsidiary
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
Taxation
Description of accounting policy for income tax [text block]
Three to four years
Later than three years and not later than four years [member]
resTORbio
resTORbio [Member]
resTORbio
Types of customers [axis]
Types of customers [axis]
Share Capital
Issued capital [member]
Income/(loss) before taxes
Profit (loss) before tax
Number of tranches
Stock Repurchase Program, Number Of Tranches
Stock Repurchase Program, Number Of Tranches
Customers over 10% of revenue
Major Customers [member]
Customers [member]
Investment in associates
Cash investment in associate
Purchase of interests in associates
Intra-group eliminations
Intra-group eliminations [Member]
Intra-group eliminations
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [table]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [table]
Accrued expenses
Accruals classified as current
Expense in respect of RSU liability award
Expense in respect of RSU liability award
Expense in respect of RSU liability award
Owners of the Company
Income/(loss) for the year, attributable to the owners of the Company
Profit (loss), attributable to owners of parent
Weighted Average [Table]
Weighted Average Options granted [Table]
Weighted Average [Table]
Non-controlling interests
Comprehensive income, attributable to non-controlling interests
Income/(loss) attributable to:
Profit (loss), attributable to [abstract]
Time to Liquidity
Time to Liquidity, measurement input [Member]
Time to Liquidity, measurement input
Statement of changes in equity [line items]
Statement of changes in equity [line items]
Over 10 percent of revenue
Over 10 percent of revenue [Member]
Over 10 percent of revenue
Segments [axis]
Segments [axis]
Net assets/(liabilities)
Net assets/(liabilities)
Assets (liabilities)
Entity's total for related parties
Entity's total for related parties [member]
Net increase (decrease) in cash and cash equivalents
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Disclosure of other financial assets
Other Financial Assets [Table Text Block]
Other Financial Assets
Weighted average grant date fair value, RSU outstanding beginning balance (in GBP per share)
Weighted average grant date fair value, RSU Ending balance (in GBP per share)
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Weighted average grant date fair value of other equity instruments outstanding in share-based payment arrangement
Lease At 6 Tide Street
Lease At 6 Tide Street [Member]
Lease At 6 Tide Street
Ranges of exercise prices for outstanding share options [axis]
Ranges of exercise prices for outstanding share options [axis]
Disclosure of weighted-average number of ordinary shares
Weighted-Average Number of Ordinary Shares [Table Text Block]
Weighted-Average Number of Ordinary Shares
Document and Entity Information [Table]
Document Information [Table]
Performance Share Plan [Table]
Performance Share Plan [Table]
Performance Share Plan [Table]
Cash flows from financing activities:
Cash flows from (used in) financing activities [abstract]
Types of interest rates [axis]
Types of interest rates [axis]
Financial assets, type [member]
Financial assets, type [member]
Disclosure of unrecognized deferred tax assets
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Supplemental disclosure of non-cash investment and financing activities:
Supplemental disclosure of non-cash investment and financing activities [Abstract]
Supplemental disclosure of non-cash investment and financing activities
Types of risks [axis]
Types of risks [axis]
Weighted average exercise price, options forfeited and expired (in GBP per share)
Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-based Payment Arrangement
Weighted Average Exercise Price Of Share Options Forfeited And Expired In Share-based Payment Arrangement
Non-controlling interests
Non-controlling interests [member]
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods [Domain]
Operating Loss Carryforwards, Expiration Periods
Ensof Biosystems, Inc. (held indirectly through Enlight)
Ensof Biosystems Inc [Member]
Ensof Biosystems Inc
Entity's total for impairment of financial assets [member]
Entity's total for impairment of financial assets [member]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Trade and other payables [abstract]
CapStar Special Purpose Acquisition Corp
CapStar Special Purpose Acquisition Corp [Member]
CapStar Special Purpose Acquisition Corp
Significant Subsidiary Plans [Table]
Significant Subsidiary Plans [Table]
Significant Subsidiary Plans [Table]
Disclosure of contract balances
Schedule of Contract Balances [Table Text Block]
Schedule of Contract Balances
Total comprehensive income/(loss) for the year
Total comprehensive income/(loss) for the year
Share of comprehensive income (loss)
Comprehensive income
Additions
Additions other than through business combinations, intangible assets other than goodwill
Contingent consideration recognised as of acquisition date
Contingent consideration recognised as of acquisition date
Valuation techniques
Valuation techniques [member]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [line items]
Dr Bharatt Chowrira
Dr Bharatt Chowrira [Member]
Dr Bharatt Chowrira
Expected term
Expected term, measurement input [Member]
Expected term, measurement input
Impairment of investment
Impairment loss (reversal of impairment loss) recognised in profit or loss
Weighted Average Options granted [Line Items]
Weighted Average Options granted [Line Items]
Weighted Average Options granted
Income/(loss) before taxes pre IFRS 9 fair value accounting, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Profit Loss Before Tax pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Profit Loss Before Tax pre IFRS 9 fair value accounting, finance costs – subsidiary preferred shares, share-based payment expense, depreciation of tangible assets and amortization of intangible assets
Disclosure of estimated useful life of assets
Disclosure of estimated useful life of assets [Table Text Block]
Disclosure of estimated useful life of assets
Weighted Average Options granted [Abstract]
Weighted Average Options granted [Abstract]
Weighted Average Options granted
Disclosure of accumulated depreciation and impairment loss
Disclosure of accumulated depreciation and impairment loss [Table Text Block]
Disclosure of accumulated depreciation and impairment loss
1.00 to 2.00
Exercise Price Range Two [Member]
Exercise Price Range Two [Member]
Related party transactions [Table]
Related party transactions [Table]
Related party transactions
2025
Two to three years
Later than two years and not later than three years [member]
Share-based payments
Share-based payments [Member]
Share-based payments
Current liabilities from share based payment transactions
Current Liabilities From Share based Payment Transactions
Current Liabilities From Share based Payment Transactions
Issuance of Subsidiary Convertible Note
Proceeds from issue of bonds, notes and debentures
Financial Instruments - Warrants [Table]
Financial Instruments - Warrants [Table]
Financial Instruments - Warrants [Table]
Disclosure of quantitative information about right-of-use assets
Disclosure of quantitative information about right-of-use assets [text block]
Investment in associates - equity method
As of period start
As of period end
Investments in associates reported in separate financial statements
Share-based Payment Expense [Abstract]
Share-based Payments [Abstract]
Share-based Payments [Abstract]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [abstract]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [abstract]
Foreign
Foreign [Member]
Foreign
Discount rate
Discount rate, measurement input [member]
Weighted-average exercise price, beginning of year (in GBP per share)
Weighted-average exercise price, end of year (in GBP per share)
Wtd Average Exercise Price (in GBP per share)
Weighted-average exercise price (in dollars per share)
Weighted average exercise price of share options outstanding in share-based payment arrangement
Basis of consolidation
Description Of Accounting Policy For Basis Of Consolidation [Policy Text Block]
Description Of Accounting Policy For Basis Of Consolidation
Weighted average number of ordinary shareholders at December 31 to calculate basic earnings per share (in shares)
Weighted average number of ordinary shares used in calculating basic earnings per share
Average effective tax rate
Average effective tax rate
Appeering Inc.
Appeering
Appeering [Member]
Appeering
Tax Losses
Tax losses expiring
Unused tax losses for which no deferred tax asset recognised
Amendment Flag
Amendment Flag
Interest rate types [member]
Interest rate types [member]
Nontrading holding companies
Nontrading Holding Companies [Member]
Nontrading Holding Companies
Lease Contractual Term [Axis]
Lease Contractual Term [Axis]
Lease Contractual Term
Cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Cash and cash equivalents
Basic earnings/ (loss) per share (in dollars per share)
Basic earnings (loss) per share
Auditor Information [Abstract]
Auditor Information
Equity Discount Rate
Equity Discount Rate, Measurement Input [Member]
Equity Discount Rate, Measurement Input
PureTech LYT (formerly Ariya Therapeutics, Inc.)
PureTech LYT
PureTech LYT [Member]
PureTech LYT
Capital and Financial Risk Management
Disclosure of financial risk management [text block]
American Depositary Shares
American Depositary Shares [Member]
American Depositary Shares
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities [Line Items]
Deferred Tax Assets and Liabilities
Deconsolidation (in shares)
Number Of Share Options Deconsolidated In Share-based Payment Arrangement
Number Of Share Options Deconsolidated In Share-based Payment Arrangement
Inactive subsidiaries
Inactive Subsidiaries [Member]
Inactive Subsidiaries
Non-cancellable contractual commitments
Contractual capital commitments
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, assets [text block]
Unearned Finance income
Unearned finance income relating to finance lease payments receivable
Gelesis Holdings Inc.
Gelesis Holdings Inc. [Member]
Gelesis Holdings Inc.
Earnings Loss per Share [Line Items]
Earnings Loss per Share [Line Items]
Earnings Loss per Share
Gains (losses) arising from difference between fair value and transaction price of derivative assets through profit or loss
Gains (Losses) Arising From Difference Between Fair Value And Transaction Price Of Derivative Assets Through Profit Or Loss
Gains (Losses) Arising From Difference Between Fair Value And Transaction Price Of Derivative Assets Through Profit Or Loss
Enlight Biosciences, LLC
Enlight (Class B Common)
Enlight [Member]
Enlight
Other temporary differences
Other temporary differences [member]
Convertible Notes [Line Items]
Convertible Notes [Line Items]
Convertible Notes
Basic
Basic [Member]
Basic
Counterparty Name [Axis]
Counterparty Name [Axis]
Discount, conversion from notes - non qualified financing
Discount, conversion from notes - non qualified financing
Discount, conversion from notes - non qualified financing
Issued ordinary shares at January 1 (in shares)
Number of shares outstanding
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Increase and Decrease Through Change In NCI Share In Subsidiary Deficit
Statement of changes in equity [abstract]
Investment in Associates
Investments in associates [Member]
Investments in associates
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans [Line Items]
Subsidiary Notes Payable - Loans
Acquisition of equity instruments in other entities
Acquisition of equity instruments in other entities
Acquisition of equity instruments in other entities
Sensitivity analysis for equity price risk, impact on pre-tax earnings
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Pre-Tax Earnings
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Impact On Pre-Tax Earnings
Deconsolidated former subsidiary operating companies
Deconsolidated former Subsidiary Operating Companies [Member]
Deconsolidated former Subsidiary Operating Companies
Weighted Average Options forfeited [Table]
Weighted Average Options forfeited [Table]
Weighted Average Options forfeited [Table]
Document Registration Statement
Document Registration Statement
Revenue [Line Items]
Revenue [Line Items]
Revenue
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Disclosure of information of employees [Line Items]
Libra Biosciences, Inc.
Libra Biosciences Inc [Member]
Libra Biosciences Inc
Percentage of reasonably possible increase in unobservable input, assets
Percentage of reasonably possible increase in unobservable input, assets
Unobservable inputs [axis]
Unobservable inputs [axis]
Nonexecutive Directors
Nonexecutive Directors [Member]
Nonexecutive Directors
Cash derecognized upon loss of control over subsidiary (see table below)
Cash In Deconsolidated Subsidiary
Cash In Deconsolidated Subsidiary
At fair value
At fair value [member]
PureTech Securities Corp.
PureTech Securities Corp. [Member]
PureTech Securities Corp.
ROU asset
Right-of-use assets [member]
Transferred over time
Goods or services transferred over time [member]
Exercise of call options, maximum number of common stocks to be purchased (in shares)
Exercise Of Call Options, Maximum Number Of Common Stocks To Be Purchased
Exercise Of Call Options, Maximum Number Of Common Stocks To Be Purchased
Maximum
Maximum [Member]
Share-based compensation expense
Adjustments for share-based payments
Disclosure of changes in equity classified non-controlling ownership interests in subsidiaries
Disclosure of interests in subsidiaries [text block]
Disclosure of credit risk
Disclosure of credit risk [text block]
2023
Less than one year
Not later than one year [member]
Customer E
Customer E [Member]
Customer E
Sensitivity analysis for equity price risk, impact on pre-tax earnings, percentage
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percentage
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Change In Risk Variable, Percentage
Dr John LaMattina and Ms Mary LaMattina
Dr John LaMattina and Ms Mary LaMattina [Member]
Dr John LaMattina and Ms Mary LaMattina
Leasehold improvements purchased through lease incentives (deducted from Right of Use Asset)
Leasehold improvements purchased through lease incentives
Leasehold improvements purchased through lease incentives
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Share-based Payments Table [Table]
Weighted Average
Significant unobservable input, assets
Cost
Principal
Gross carrying amount [member]
NCI exercise of stock options in subsidiary
Proceeds From Issue Of shares to NCI
Proceeds From Issue Of shares to NCI
Disclosure of accumulated amortization
Disclosure of Accumulated amortization [Table Text Block]
Disclosure of Accumulated amortization
Preferred D shares
Preferred D shares [Member]
Preferred D shares
Customer C
Customer C [Member]
Customer C
Other research and development expenses
Other Research And Development Expense
Other Research And Development Expense
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Unrecognized deferred tax assets [Line Items]
Outstanding at beginning of period (in shares)
Outstanding at end of period (in shares)
Number of share options (in shares)
Number of share options outstanding in share-based payment arrangement
Conversion to subsidiary preferred shares
Conversion to preferred
Conversion to preferred
Short-term note from associate
Current receivables due from associates
Current receivables due from associates
Non deductible share based payment expenses
Rate of Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Rate of Share based Payment expenses, non-deductible
Deferred tax assets (liabilities), net, not recognized
Total
Net deferred tax assets, not recognised
Net deferred tax assets, not recognised
Title of 12(b) Security
Title of 12(b) Security
Disclosure of weighted average exercise prices for options granted
Disclosure of Weighted Average Exercise Prices for Options Granted [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Granted
Payroll taxes
Payroll Taxes
Payroll Taxes
Unrecognised share of losses of associates, other comprehensive loss
Unrecognised share of losses of associates, other comprehensive loss
Unrecognised Share Of Losses Of Associates, Other Comprehensive Loss
Unrecognised Share Of Losses Of Associates, Other Comprehensive Loss
Total Lease Receivable
Finance lease receivables
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Subsidiary Notes Payable [Abstract]
Non-controlling Interest
Disclosure of non-controlling interests [text block]
Calculation of number of securities called by warrants or rights, multiplier
Class of Warrant or Right, Calculation Of Number of Securities Called by Warrants or Rights, Multiplier
Class of Warrant or Right, Calculation Of Number of Securities Called by Warrants or Rights, Multiplier
MASSACHUSETTS
MASSACHUSETTS
Issuance of convertible notes
Issuance Of Convertible Notes [Member]
Issuance Of Convertible Notes
Other
Other inflows (outflows) of cash, classified as financing activities
Weighted average remaining contractual life of options excisable (in years)
Weighted average remaining contractual life of options excisable
Weighted average remaining contractual life of options excisable
Statement Of Cash Flows [Table]
Statement Of Cash Flows [Table]
Statement Of Cash Flows [Table]
Liquidity Risk [Line Items]
Liquidity Risk [Line Items]
Liquidity Risk
All levels of fair value hierarchy
All levels of fair value hierarchy [member]
Entity Address, Country
Entity Address, Country
Gain/(loss) on foreign currency exchange
Gain Loss on foreign currency exchange in finance costs
Gain Loss on foreign currency exchange in finance costs
Vor Biopharma Inc.
Vor
Vor [Member]
Vor
Not impaired
Not impaired [Member]
Not impaired
Disclosure of maturity analysis of finance lease payments receivable
Disclosure of maturity analysis of finance lease payments receivable [text block]
Deconsolidation of subsidiary
Increase (decrease) through change in equity of subsidiaries, equity
Balance before allocation of share in associate loss to long-term interest
Financial Assets At Fair Value Through Profit Or Loss before allocation to long-term interest
Financial Assets At Fair Value Through Profit Or Loss before allocation to long-term interest
Financial Liabilities
Description of accounting policy for financial liabilities [text block]
Total current liabilities
Current liabilities
Current liabilities
Disclosure of financial assets [abstract]
Calculation of number of securities called by warrants or rights, number of trading days
Class of Warrant or Right, Calculation Of Number of Securities Called by Warrants or Rights, Number Of Trading Days
Class of Warrant or Right, Calculation Of Number of Securities Called by Warrants or Rights, Number Of Trading Days
Gross Amount
Gross Amount [Member]
Gross Amount
Debt Discount Rate
Debt Discount Rate, Measurement Input [Member]
Debt Discount Rate, Measurement Input
Translation reserve
Reserve of exchange differences on translation [member]
Level 2 of fair value hierarchy
Level 2 of fair value hierarchy [member]
Non-Controlling Interests [Table]
Non-Controlling Interests [Table]
Non-Controlling Interests
Finance Cost, net
Disclosure of finance cost [text block]
Long-term loan [Abstract]
Long-term loan [Abstract]
Equity settled share-based awards
Increase (decrease) through share-based payment transactions, equity
Investments in Associates
Disclosure of associates [text block]
Karuna, Vor and Akili
Karuna, Vor and Akili [Member]
Karuna, Vor and Akili
Minimum liquidation preference [Abstract]
Minimum liquidation preference [Abstract]
Minimum liquidation preference
Payment of lease liability
Cash paid for rent - principal - financing cash flow
Payments of lease liabilities, classified as financing activities
Total revenue
Revenue
Total revenue
Revenue
Payables to related parties
Payables to related parties
Share premium
Share premium [member]
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Recognised Income Tax Expense [Table]
Reconciliation of Effective Tax Rate [Table]
Reconciliation of Effective Tax Rate [Table]
Reconciliation of Effective Tax Rate [Table]
Gelesis and Sonde
Gelesis And Sonde [Member]
Gelesis And Sonde
Sensitivity range, decrease
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Period
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Decrease In Risk Variable, Period
Contractual interest expense on notes payable
Contractual Interest expense on notes
Contractual Interest expense on notes
Proportion of ownership interest in subsidiary, additional ownership acquired
Proportion of ownership interest in subsidiary, additional ownership acquired
Proportion of ownership interest in subsidiary, additional ownership acquired
New Standards and Interpretations Not Yet Adopted
Disclosure of expected impact of initial application of new standards or interpretations [text block]
Deferred tax liability
Deferred tax liabilities
Deferred tax liabilities
Document Accounting Standard
Document Accounting Standard
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Convertible notes
Convertible Notes [Member]
Convertible Notes
Credit Risk Abstract [Abstract]
Liquidity Risk [Abstract]
Liquidity Risk
Investments in associates accounted for using equity method
Investment in Sonde - deconsolidation
Investments in associates accounted for using equity method
Convertible instruments, interest rate
Convertible instruments, interest rate
Convertible instruments, interest rate
Statement of cash flows [abstract]
Warrant liability
Current derivative financial liabilities
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Weighted Average Options outstanding [Table]
Financial Instruments - Warrants [Roll Forward]
Financial Instruments - Warrants [Roll Forward]
Financial Instruments - Warrants
Weighted average exercise price (in dollars per share)
Weighted average exercise price of share options forfeited in share-based payment arrangement
Series 3 growth preferred stock
Series 3 Growth Preferred Stock [Member]
Series 3 Growth Preferred Stock
Investments held at fair value [Table]
Investments held at fair value [Table]
Investments held at fair value
Disclosure of range of assumptions of fair value of stock option grants
Significant Subsidiary Plan -Vedanta 2010 Plan - Range of assumptions of Fair Value of stock option grants [Table Text Block]
Significant Subsidiary Plan - Vedanta - Range of assumptions of Fair Value of stock option grants
Financial Instruments - Warrants [Line Items]
Financial Instruments - Warrants [Line Items]
Financial Instruments - Warrants
Current year losses for which no deferred tax asset is recognized
Tax rate effect of tax losses
R&D and orphan drug tax credits
Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Research And Development and orphan drug tax credits, reconciliation of effective tax rate
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Subsidiary Plans [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Table]
Summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Exercised (in shares)
Number of share options exercised (in dollars per share)
Number of share options exercised in share-based payment arrangement
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. [Member]
Dewpoint Therapeutics, Inc.
Disclosure of recognized income tax expense
Disclosure of recognized income tax expense [Table Text Block]
Disclosure of recognized income tax expense
Weighted Average Options forfeited [Abstract]
Weighted Average Options forfeited [Abstract]
Weighted Average Options forfeited
Total liabilities
Total liabilities
Liabilities
Income/(loss) attributable to ordinary shareholders
Profit Loss Attributable To Ordinary Shareholders
Profit Loss Attributable To Ordinary Shareholders
Operating Expenses
Disclosure Of Operating Expense Explanatory [Text Block]
Disclosure Of Operating Expense Explanatory
Additions
Additions to right-of-use assets
Lease Liability
Lease liabilities [member]
Fair value of equity investment
Fair Value Of Equity Investment
Fair Value Of Equity Investment
Write-off
Impairment loss recognised in profit or loss, intangible assets other than goodwill
2.00 to 3.00
Exercise Price Range Three [Member]
Exercise Price Range Three [Member]
Accounting Policies
Accounting Policies [Line Items]
Accounting Policies
Net cash provided by (used in) investing activities
Cash flows from (used in) investing activities
Leases [Abstract]
Leases [Abstract]
Leases [Abstract]
Finance lease payments receivable [Line Items]
Finance lease payments receivable [Line Items]
Finance lease payments receivable
Current Fiscal Year End Date
Current Fiscal Year End Date
PureTech and third-party
PureTech and third-party [Member]
PureTech and third-party
Non-Controlling Interests [Line Items]
Non-Controlling Interests [Line Items]
Non-Controlling Interests
Customer F
Customer F [Member]
Customer F
Property and Equipment
Disclosure of property, plant and equipment [text block]
Amortization
Amortisation, intangible assets other than goodwill
Deferred tax assets and liabilities [abstract]
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Minimum liquidation preference [Table]
Gain/(loss) from change in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Gain/(Loss) from change in fair value of warrant liability
Disclosure of fair value measurement and classification
Disclosure of fair value measurement [text block]
Current liabilities
Current liabilities [abstract]
Weighted average exercise price, options granted (in GBP per share)
Weighted average exercise price (in dollars per share)
Weighted average exercise price of share options granted in share-based payment arrangement
PureTech Management, Inc.
PureTech Management [Member]
PureTech Management
2017 performance based RSU
2017 Performance Based RSU [Member]
2017 Performance Based RSU
Taxation [Table]
Taxation [Table]
Taxation
Purchase of property and equipment
Purchase of property, plant and equipment, classified as investing activities
Top of range
Top of range [member]
Audit of the financial statements of subsidiaries
Audit of financial statements of subsidiaries
Audit of financial statements of subsidiaries
Borrowings, interest rate
Borrowings, interest rate
Preferred A-1 Shares
Preferred A-1 Shares [Member]
Preferred A-1 Shares
Disclosure of reconciliation of effective tax rate
Disclosure of Reconciliation of Effective Tax Rate [Table Text Block]
Disclosure of Reconciliation of Effective Tax Rate
Earnings/(Loss) attributable to owners of the Company [Abstract]
Earnings/(Loss) attributable to owners of the Company [Abstract]
Earnings/(Loss) attributable to owners of the Company
Percentage of reasonably possible decrease in unobservable input, assets
Percentage of reasonably possible decrease in unobservable input, assets
Weighted average grant date fair value, RSU forfeited (in GBP per share)
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Weighted average grant date fair value of other equity instruments forfeited in share-based payment arrangement
Intangible assets other than goodwill
Intangible assets other than goodwill [member]
Mandara Sciences, LLC
Mandara Sciences LLC [Member]
Mandara Sciences LLC
Disclosure of total operating expense
Disclosure Of Total Operating Expense Explanatory [Table Text Block]
Disclosure Of Total Operating Expense Explanatory
Deferred revenue – short term
Current contract liabilities
Disclosure of payroll costs
Disclosure of Payroll Costs [Table Text Block]
Disclosure of Payroll Costs
Total other comprehensive income/(loss)
Other comprehensive income/(loss), net
Other comprehensive income/(loss)
Other comprehensive income
Share-based payment arrangements, percentage of common shares outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Share-based Payment Arrangements, Authorized Amount, Percentage of Common Shares Outstanding
Gain/(loss) on investment held at fair value
Investment retained in deconsolidated subsidiary
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, assets
Gain/(loss) from change in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Gain/(Loss) from change in fair value of preferred shares
Consolidated Statements of Comprehensive Income/(Loss)
Statement of comprehensive income [abstract]
Intangible assets, net
Balance at beginning of period
Balance at end of period
Intangible assets other than goodwill
Operating Expense Category [Axis]
Operating Expense Category [Axis]
Operating Expense Category
Basis of Measurement
Explanation of measurement bases used in preparing financial statements [text block]
Decrease in value of preferred shares measured at fair value – finance costs (income)
Change in fair value
Change in fair value
Change in fair value
Disclosure of maturity analysis of operating lease payments [line items]
Disclosure of maturity analysis of operating lease payments [line items]
Accounting Policies [Table]
Accounting Policies [Table]
Accounting Policies [Table]
Intangible Assets [Abstract]
Intangible Assets [Abstract]
Intangible Assets
Disclosure of information about employees
Disclosure of information about employees [text block]
Associates
Description of accounting policy for investment in associates [text block]
One year to Five Years
Later than one year and not later than five years [member]
Short-term note [Abstract]
Short-term note [Abstract]
Short-term note
Weighted Average Options exercised [Abstract]
Weighted Average Options exercised
Leases
Disclosure of leases [text block]
Royalty income
Royalty income
Property, plant and equipment [abstract]
Par value per share (in GBP per share)
Par value per share
Cash and Cash Equivalents
Description of accounting policy for restricted cash and cash equivalents [text block]
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification [Line Items]
Financial Instruments - Fair value Measurement and Classification
Capstar
Capstar [Member]
Capstar
Convertible Notes [Table]
Convertible Notes [Table]
Convertible Notes [Table]
Lease liability, subleased area (in square feet)
Lease Liability, Subleased Area
Lease Liability, Subleased Area
Total
Key management personnel compensation
Accumulated amortization
Accumulated depreciation and amortisation [member]
Finance costs
Finance costs [Abstract]
Finance costs
Liabilities, intercompany eliminations between parent company and reportable segments
Liabilities, intercompany eliminations between parent company and reportable segments
Liabilities, intercompany eliminations between parent company and reportable segments
Entity Central Index Key
Entity Central Index Key
Other assets and liabilities, net
Other Assets And Liabilities, Net
Other Assets And Liabilities, Net
Leases - Rental [Table]
Leases - Rental [Table]
Leases - Rental [Table]
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Subsidiary Types [Domain]
Balance at beginning of period before allocation of associate loss to long-term interest
Balance at end of period before allocation of associate loss to long-term interest
Financial assets, at fair value
Financial assets
Financial assets, at fair value
Reclassification of Vor from level 3 to level 1
Transfers out of Level 3 of fair value hierarchy, assets
Expected terms (in years)
Option life, share options granted
Entity [Domain]
Entity [Domain]
City Area Code
City Area Code
Business combination, additional shares to be received at no additional cost, fair value
Business Combination, Additional Shares To Be Received At No Additional Cost, Fair Value
Business Combination, Additional Shares To Be Received At No Additional Cost, Fair Value
Timing of transfer of goods or services [axis]
Timing of transfer of goods or services [axis]
Weighted average number of ordinary shareholders at December 31 to calculate diluted earnings per share (in shares)
Weighted average number of ordinary shares used in calculating diluted earnings per share
Expired During the Year
Number of share options expired in share-based payment arrangement
Auditor's remuneration
Auditor's remuneration
Consideration for acquired non-controlling interest, first installment
Consideration for acquired non-controlling interest, first installment
Consideration for acquired non-controlling interest, first installment
One Unnamed Investor
One Unnamed Investor [Member]
One Unnamed Investor
Information about credit quality of neither past due nor impaired financial assets
Information about credit quality of neither past due nor impaired financial assets [text block]
Financial Instruments
Disclosure of financial instruments [text block]
Investments held at fair value [Line Items]
Investments held at fair value [Line Items]
Investments held at fair value
Disclosure of operating segments [line items]
Disclosure of operating segments [line items]
Investments held at fair value
Investments held at fair value [Member]
Investments held at fair value
Share price at grant date
Weighted average share price, share options granted
Segment consolidation items [axis]
Segment consolidation items [axis]
Earnings Loss per Share [Table]
Earnings Loss per Share [Table]
Earnings Loss per Share [Table]
Debt instrument, payment terms, final fee trigger amount
Debt instrument, payment terms, final fee trigger amount
Debt instrument, payment terms, final fee trigger amount
Subsidiaries [axis]
Subsidiaries [axis]
Borrowings, adjustment to interest rate basis
Borrowings, adjustment to interest rate basis
Acquisition cost
Acquisition cost
Acquisition cost
Change in blended state rate impact due to state apportionment change
Adjustments Related To Change In Blend State Rate
Adjustment Related To Change In Blend State Rate
Transferred at a point in time – licensing income
Goods or services transferred at point in time [member]
Partial settlement of share based liability awards and settlement of equity based RSUs (in shares)
Number Of Ordinary Shares Issued To Settle Share-based Payment Awards
Number Of Ordinary Shares Issued To Settle Share-based Payment Awards
Percent voting rights of the Companny
Percent voting rights of the Company
Percent voting rights of the Company
Current receivable due from associates, interest rate
Current Receivable Due From Associates, Interest Rate
Current Receivable Due From Associates, Interest Rate
Disclosure of income taxes recognized in comprehensive income
Disclosure of Income Taxes Recognized in Comprehensive Income [Table Text Block]
Disclosure of Income Taxes Recognized in Comprehensive Income
Total current income tax expense/(benefit)
Current tax expense (income)
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares [Line Items]
Subsidiary Preferred Shares
Disclosure of equity
Summary of Equity [Table Text Block]
Summary of Equity
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [abstract]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [abstract]
Effects of state tax rate in U.S.
Effects of state tax rate in US, reconciliation of effective tax rate
Effects of state tax rate in US, reconciliation of effective tax rate
Deferred tax assets (liabilities), net
Deferred tax liability (asset)
Categories of related parties [axis]
Categories of related parties [axis]
Taxation [Line Items]
Taxation [Line Items]
Taxation
Disclosure of stock option activity
Disclosure of number and weighted average exercise prices of share options [text block]
Statement of changes in equity [table]
Statement of changes in equity [table]
Gain on deconsolidation of subsidiary
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
Tax credits
Unused tax credits [member]
Financial Liability Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, liabilities
RSU [Abstract]
RSU
Performance, market and service based RSU
Performance, market and service based RSU [Member]
Performance, market and service based RSU
NCI exercise of share-based awards in subsidiaries - change in NCI interest
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity
Classes of financial liabilities [axis]
Classes of financial liabilities [axis]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Purchase of short-term note from associate
Payment To Acquire Short-term Notes Receivable From Associate
Payment To Acquire Short-term Notes Receivable From Associate
Intangible Assets
Disclosure of detailed information about intangible assets [line items]
Net assets (deficit) attributable to shareholders of Gelesis Inc.
Net assets attributable to shareholders of associate
Net assets attributable to shareholders of associate
Number of share options granted in share-based payment arrangement (in shares)
Granted (in shares)
Number of share options granted in share-based payment arrangement
Business combination, number of shares received for additional cost (in shares)
Business Combination, Number Of Shares Received
Business Combination, Number Of Shares Received
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards [Table]
Directors and Senior Managers Shareholdings and Share Incentive awards
PureTech Securities II Corp.
PureTech Securities II Corp. [Member]
PureTech Securities II Corp.
Total other financial assets
Other financial assets
Money Markets
Loans to corporate entities [member]
Share price of investee shares (in dollars per share)
Share price of investee shares
Share price of investee shares
Retained earnings/(accumulated deficit)
Retained earnings
Forfeited (in shares)
Number of other equity instruments forfeited in share-based payment arrangement
Weighted average assumptions [Abstract]
Share-based payment - Weighted average assumptions
Partial settlement of share based liability awards and settlement of equity based RSUs
Ordinary Shares Issued To Settle Share-based Payment Awards
Ordinary Shares Issued To Settle Share-based Payment Awards
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Total Business Or Sourcing Company [Member]
Total Business Or Sourcing Company [Member]
Total Business Or Sourcing Company
Carrying Amount
Carrying amount [member]
Number of shares held (in shares)
Number Of Shares Held
Number Of Shares Held
Lease receivable – short-term
Short-term Portion of Lease Receivable
Current finance lease receivables
Disclosure of associates [Line Items]
Disclosure of associates [Line Items]
Disclosure of associates
Prepaid expenses
Adjustments for decrease (increase) in other current assets
Disclosure of financial liabilities - warrants, weighted-average assumptions
Disclosure of financial liabilities - Warrants, weighted-average assumptions [Table Text Block]
Disclosure of financial liabilities - Warrants, weighted-average assumptions
Consideration for acquired non-controlling interest
Consideration for acquired non-controlling interest
Consideration for acquired non-controlling interest
Depreciation
Depreciation
Depreciation, right-of-use assets
Net finance income/(costs)
Finance income/(costs), net
Finance income (cost)
Earnings/(loss) per share:
Earnings per share [abstract]
Dr John LaMattina (individually)
Dr John LaMattina (individually) [Member]
Dr John LaMattina (individually)
Disclosure of range of exercise prices of outstanding share options
Disclosure of range of exercise prices of outstanding share options [text block]
Significant Subsidiary Plans [Line Items]
Significant Subsidiary Plans [Line Items]
Significant Subsidiary Plans [Line Items]
Stock options
Stock Options [Member]
Stock Options
Related Party Transactions - Key Management Personnel Compensation [Abstract]
Related Party Transactions - Key Management Personnel Compensation
Non-controlling interests
Non-controlling interests
Non-controlling interests
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Unobservable inputs
Unobservable inputs [member]
Intangible Assets
Disclosure of intangible assets [text block]
Sale of Karuna shares
Sales, fair value measurement, assets
Commitments And Contingencies [Abstract]
Commitments And Contingencies [Abstract]
Gross principal - issuance of notes - financing activity
Gross Principal
Gross Principal
Reclassification of equity settled awards to liability awards
Increase Decrease in reclassification of equity settled awards into liability awards
Increase Decrease in reclassification of equity settled awards into liability awards
Vested (in shares)
Number of other equity instruments exercised or vested in share-based payment arrangement
Finance income/(costs) – fair value accounting
Finance income/(costs) – IFRS 9 fair value accounting
Total finance income/(costs) – fair value accounting
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities
Profit or loss [abstract]
Revaluation of deferred tax assets related to share-based awards
Decrease (increase) through tax on share-based payment transactions, equity
Finance income/(costs) – fair value accounting
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Rate of finance income costs - fair value accounting, reconciliation of effective tax rate
Exercise price (in dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Class of Warrant or Right, Exercise Price of Warrants or Rights
Audit of financial statements of associates
Audit of financial statements of associates
Audit of financial statements of associates
Karuna Therapeutics, Inc.
Karuna
Karuna [Member]
Karuna
Earnings Category Axis [Axis]
Earnings Category [Axis]
Earnings Category
Lease liability, renewal term
Lease Liability, Renewal Term
Lease Liability, Renewal Term
Receipt of PPP loan
Proceeds from current borrowings
Sale of royalty interest, contingent consideration (up to)
Sale Of Royalty Interest, Contingent Consideration
Sale Of Royalty Interest, Contingent Consideration
Subsequent Events
Disclosure of events after reporting period [text block]
Reclassification of Akili to level 1 investment
Reclassification of investment to investment in associate
Reclassification of investment to investment in associate
Weighted Average
Significant unobservable input, liabilities
Weighted Average Options exercised [Table]
Weighted Average Options exercised [Table]
Weighted Average Options exercised
Share-based payment arrangement, cash settlement value
Share-based Payment Arrangement, Cash Used to Settle Award
Share-based Payment Arrangement, Cash Used to Settle Award
Share based liability awards
Share based liabilty awards [Member]
Share based liabilty awards
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. [Member]
Karuna Therapeutics, Inc.
State
State [Member]
State
Performance obligations [member]
Performance obligations [member]
Repayment of short-term Note from associate
Cash Receipts From Repayment Of Current Receivables Due From Associates, Classified As Investing Activities
Cash Receipts From Repayment Of Current Receivables Due From Associates, Classified As Investing Activities
Other financial assets
Restricted cash
Restricted cash and cash equivalents
Total operating expense
Operating income/(loss)
Operating income/(loss)
Operating expense
Disclosure of detailed information about borrowings [table]
Disclosure of detailed information about borrowings [table]
Document Annual Report
Document Annual Report
Purchase of Treasury stock
Purchase of treasury shares
Disclosure of disaggregation of revenue from contracts with customers [line items]
Disclosure of disaggregation of revenue from contracts with customers [line items]
Legal Entity [Axis]
Legal Entity [Axis]
Aggregated measurement
Aggregated measurement [member]
Number of associate's common stock held at fair value
Number of associate common stock held at fair value
Number of associate common stock held at fair value
Research and development
Research And Development [Member]
Research And Development
Consideration for acquired non-controlling interest, second installment
Consideration for acquired non-controlling interest, second installment
Consideration for acquired non-controlling interest, second installment
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Significant Subsidiary Plans [Abstract]
Significant Subsidiary Plans [Abstract]
Significant Subsidiary Plans
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets
Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, assets
Finance income/(costs):
Finance income/(costs) [Abstract]
Finance income/(costs)
Sale of equity instruments in other entities (in shares)
Sale of equity instruments in other entities
Sale of equity instruments in other entities
Performance obligations satisfied over
Performance obligations satisfied over time [member]
Income tax receivable
Current tax assets, current
Commitments and Contingencies [Table]
Commitments and Contingencies [Table]
Commitments and Contingencies
Vedanta Biosciences
Vedanta
Vedanta Biosciences [Member]
Vedanta Biosciences
Current assets
Current assets [abstract]
Other reserve
Other reserves
Disclosure of earnings/(loss) attributable to owners of company
Earnings Loss attributable to owners of company [Table Text Block]
Earnings Loss attributable to owners of company
Neither past due nor impaired [Abstract]
Trade and other receivables not impaired [Abstract]
Trade and other receivables not impaired
Performance based RSU
Performance based RSU [Member]
Performance based RSU
Laboratory and manufacturing equipment
Laboratory and Manufacturing Equipment [Member]
Laboratory and Manufacturing Equipment
2024
One to two years
Later than one year and not later than two years [member]
Leases
Description of accounting policy for leases [text block]
Entity Shell Company
Entity Shell Company
Interest expense on other borrowings
Interest expense on borrowings
Disclosure of detailed information about borrowings [line items]
Disclosure of detailed information about borrowings [line items]
Trade and other receivables not impaired [Table]
Trade and other receivables not impaired [Table]
Neither Past due or impaired [Table]
Capital And Financial Risk Management [Abstract]
Capital And Financial Risk Management
Within 10 years
Not later than 10 years [Member]
Not later than 10 years
Miscellaneous other operating expense
Miscellaneous other operating expense
Auditors Remuneration [Line Items]
Auditors Remuneration [Line Items]
Auditors Remuneration [Line Items]
Assets
Assets [member]
Akili Interactive Labs, Inc.
Akili Interactive Labs [Member]
Akili Interactive Labs
Document Period End Date
Document Period End Date
Disclosure of subsidiary preferred shares, minimum liquidation preference
Summary of Minimum liquidation preference [Table Text Block]
Summary of Minimum liquidation preference
Summary of investments in associates
Summary of Investments in Associates [Table Text Block]
Summary of Investments in Associates
Total Income Tax Type
Total Income Tax Type [Member]
Total Income Tax Type
PureTech LYT-100
PureTech LYT - 100 [Member]
PureTech LYT - 100
Employee Benefits
Description of accounting policy for employee benefits [text block]
Customer D
Customer D [Member]
Customer D
Total equity and liabilities
Equity and liabilities
Treasury Shares
Treasury shares [member]
Sale of royalty interest, expected consideration
Sale Of Royalty Interest, Consideration, Expected
Sale Of Royalty Interest, Consideration, Expected
Share-based Payment [Line Items]
Share-based Payment [Line Items]
Share-based Payment
Financial liabilities, class
Financial liabilities, class [member]
Outstanding (Non-vested), beginning of year (in shares)
Outstanding (Non-vested), end of year (in shares)
Number of RSUs held (in shares)
Number of other equity instruments outstanding in share-based payment arrangement
Accrued interest – contractual
Accrued interest - contractual
Accrued interest - contractual
Total parent equity
Equity attributable to owners of parent [member]
Deferred revenue
Current government grants
Finance income/(costs) – subsidiary preferred shares
Finance income/(costs) - subsidiary preferred shares
Finance income/(costs) - subsidiary preferred shares
Net cash provided by (used in) financing activities
Cash flows from (used in) financing activities
Gains (losses) on change in fair value of equity investments
Gains (Losses) On Change In Fair Value Of Equity Investments
Gains (Losses) On Change In Fair Value Of Equity Investments
Non-controlling interests
Profit (loss), attributable to non-controlling interests
Series C-2 preferred
Series C-2 Preferred [Member]
Series C-2 Preferred
Interest expense on lease liability
Interest expense
Interest expense on lease liabilities
Diluted
Diluted [Member]
Diluted
Weighted Average Options exercisable [Abstract]
Weighted Average Options exercisable [Abstract]
Weighted Average Options exercisable
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Disclosure of information of employees [Table]
Accrued interest
Borrowings, Accrued Interest
Borrowings, Accrued Interest
Useful life measured as period of time, property, plant and equipment
Useful life measured as period of time, property, plant and equipment
Value of ahares authorized to be repurchased
Stock Repurchase Program, Shares Authorized to be Repurchased
Stock Repurchase Program, Shares Authorized to be Repurchased
Types of customers
Types of customers [member]
Total
Total Operating Expense [Member]
Total Operating Expense
Finance (income)/costs, net
Adjustments For Finance Costs (Income)
Adjustments For Finance Costs (Income)
Short-term employee benefits
Key management personnel compensation, short-term employee benefits
Convertible Notes [Roll Forward]
Convertible Notes [Roll Forward]
Convertible Notes
Measurement [axis]
Measurement [axis]
Gain/(loss) on disposal of assets
Gains (losses) on disposals of non-current assets
Liability settled share based awards
Other payables, liability settled share based awards
Other payables, liability settled share based awards
Entity Address, City or Town
Entity Address, City or Town
Payments in respect of developmental milestones, dependent on events outside control of company, but reasonably possible to occur
Estimated financial effect of contingent liabilities
Leasehold improvements
Leasehold improvements [member]
Expiring [Axis]
Expiring [Axis]
Expiring
Convertible instruments, discount rate
Convertible instruments, discount rate
Convertible instruments, discount rate
Derivative Asset, Backstop Agreement
Derivative Asset, Backstop Agreement [Member]
Derivative Asset, Backstop Agreement
Financial Liability Increase/ (Decrease)
Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, liabilities
Shares remaining available for issuance (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Shares Remaining Available For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Remaining Available For Issuance
Auditor Name
Auditor Name
Cash paid for rent - interest
Cash outflow for leases
Property, plant and equipment
Disclosure of detailed information about property, plant and equipment [line items]
Significant Subsidiary Plan [Line Items]
Significant Subsidiary Plan [Line Items]
Significant Subsidiary Plan
Share-based compensation expense
Adjustments for fair value losses (gains)
Share of profit (loss) of associates accounted for using equity method
Share of profit (loss) of associates accounted for using equity method
Disclosure of property & equipment, net
Schedule of Property & Equipment net [Table Text Block]
Schedule of Property & Equipment net
Number of earnout shares received from SPAC exchange (in shares)
Financial Investments, Number Of Earnout Shares Received From SPAC Exchange
Financial Investments, Number Of Earnout Shares Received From SPAC Exchange
PureTech Health LLC
PureTech Health LLC
PureTech Health [Member]
PureTech Health
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants [Table Text Block]
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities, warrants
Disclosure of maturity analysis of operating lease payments
Disclosure of maturity analysis of operating lease payments [text block]
Disclosure of changes in the value of subsidiary preferred shares
Changes in the value of subsidiary preferred shares [Table Text Block]
Changes in the value of subsidiary preferred shares
Translation reserve
Reserve of exchange differences on translation
Stock committed to acquire during period (in dollars per share)
Stock Committed To Acquire During Period, Price Per Share
Stock Committed To Acquire During Period, Price Per Share
Prepaid expenses
Current prepaid expenses
Lease liability, current
Short-term Portion of Lease Liability
Current lease liabilities
Deconsolidation of subsidiary
Increase (decrease) through disposal of subsidiary, equity
Vesting of share-based awards and net share exercise
Increase Decrease through vesting of share based awards and net share exercise, equity
Increase Decrease through vesting of share based awards and net share exercise, equity
Entity's total for associates
Entity's total for associates [member]
Liquidity Risk [Table]
Liquidity Risk [Table]
Liquidity Risk [Table]
Non-current assets
Non-current assets [abstract]
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management [Table]
Capital And Financial Risk Management
Receivables due from related parties
Receivables due from related parties
Computer equipment and software
Computer equipment [member]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items]
Number of shares issued and fully paid (in shares)
Number of shares issued and fully paid
Disclosure of other operating expense
Disclosure of other operating expense [text block]
Ranges of exercise prices for outstanding share options
Ranges of exercise prices for outstanding share options [member]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding [Line Items]
Weighted Average Options Outstanding
Share of net loss in Gelesis
Share of profit (loss) from continuing operations of associates and joint ventures accounted for using equity method
Disclosure of key management personnel compensation
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]
Expected volatility
Expected volatility, share options granted
Capitalized Research & Experimental Expenditures
Capitalized Research And Experimental Expenditures [Member]
Capitalized Research And Experimental Expenditures
Deconsolidation of subsidiaries
Increase (Decrease) From Adjustment To Loss Of Control Of Subsidiary, Intangible Assets Other Than Goodwill
Increase (Decrease) From Adjustment To Loss Of Control Of Subsidiary, Intangible Assets Other Than Goodwill
Forfeited and expired (in shares)
Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement
Number Of Share Options Forfeited And Expired In Share-Based Payment Arrangement
Operating expenses:
Operating Expenses [Abstract]
Operating Expenses
Current financial liabilities
Subsidiary notes payable
Beginning balance
Ending balance
Current financial liabilities
Interest income from financial assets
Interest income for financial assets not at fair value through profit or loss
Trade and other payables
Trade and other payables [Member]
Trade and other payables
Total income tax expense/(benefit), recognized
Deferred tax expense (income) recognised in profit or loss
Earnings/(Loss) per Share
Disclosure of earnings per share [text block]
Property and Equipment
Description of accounting policy for property, plant and equipment [text block]
Counterparty Name [Domain]
Counterparty Name [Domain]
Impairment of investment in associate
Impairment of investment in associate
Impairment
Impairment loss recognised in profit or loss
Director
Director [Member]
Disclosure of share-based payment expense as reflected in the Consolidated Statement of Income/(Loss)
Share-based Payment Expense Table [Text Block]
Share-based Payment Expense Table
Level 1 of fair value hierarchy
Level 1 of fair value hierarchy [member]
Non deductible share based payment expenses
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Share based Payment expenses, non-deductible, reconciliation of effective tax rate
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods [Axis]
Operating Loss Carryforwards, Expiration Periods
Vesting of restricted stock units and net share exercise
Vesting of restricted stock units
Vesting of restricted stock units
Liability for share based awards
Non current Liabilities From Share based Payment Transactions
Non current Liabilities From Share based Payment Transactions
Share-based payment expense
Key management personnel compensation, share-based payment
Going Concern
Description Of Accounting Policy For Going Concern [Policy Text Block]
Description Of Accounting Policy For Going Concern
Beginning balance number of shares outstanding (in shares)
Ending balance number of shares outstanding (in shares)
Number of shares issued (in shares)
Number of shares issued
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Accounting Policies - Property and Equipment [Table]
Disclosure of intangible assets, net
Schedule of Intangible assets net [Table Text Block]
Schedule of Intangible assets net
Revenue [Table]
Revenue [Table]
Revenue
PWERM based on pro forma backsolve approach that leverages a Monte Carlo simulation
Market, PWERM and Hybrid allocation [Member]
Market, PWERM and Hybrid allocation
Long-term loan [Member]
Long-term loan [Member]
Long-term loan
Entrega, Inc. (indirectly held through Enlight)
Entrega
Entrega [Member]
Entrega
Disclosure of changes in assets, level 3 fair value - investments held at fair value
Disclosure of changes in assets, level 3 fair value - investments held at fair value [Table Text Block]
Disclosure of changes in assets, level 3 fair value - investments held at fair value
Disclosure of subsidiary share-based payments
Disclosure of Subsidiary Share-based Payment Plans [Table Text Block]
Disclosure of Subsidiary Share-based Payment Plans
Proceeds from sale of property and equipment
Proceeds from sales of property, plant and equipment, classified as investing activities
Market Backsolve & OPM
Market, Backsolve and OPM allocation [Member]
Market, Backsolve and OPM allocation
Goodwill
Goodwill
Vedanta Biosciences Securities Corp. (indirectly held through Vedanta)
Vedanta Biosciences Securities Corp [Member]
Vedanta Biosciences Securities Corp
Share-Based Payment Arrangements [Abstract]
Share-Based Payment Arrangements [Abstract]
Total deferred income tax expense/(benefit)
Deferred tax expense (income)
Document Shell Company Report
Document Shell Company Report
Changes in operating assets and liabilities:
Changes in operating assets and liabilities [Abstract]
Changes in operating assets and liabilities
Weighted Average number of ordinary shares [Line Items]
Weighted Average number of ordinary shares [Line Items]
Weighted Average number of ordinary shares
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Share-based Payments
Disclosure of share-based payment arrangements [text block]
Realized loss on sale of investments
Realized loss on sale of investments
Realized loss on sale of investments
Losses on disposals of investments
Total
Credit exposure
Notes Payable [Table]
Notes Payable [Table]
Notes Payable
Trade and other receivables
Trade and other current receivables
Additional investment as a result of backstop settlement (see above)
SPAC Exchange, Additional Investment In Associates
SPAC Exchange, Additional Investment In Associates
Notes payable
Subsidiary notes payable
Notes and debentures issued
Classes of assets [axis]
Classes of assets [axis]
Temporary difference, unused tax losses and unused tax credits [axis]
Temporary difference, unused tax losses and unused tax credits [axis]
Other
Increase (decrease) through other changes, equity
Share approved for issuance (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Shares Approved For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Shares Approved For Issuance
Treasury Shares
Description of accounting policy for treasury shares [text block]
Increase in shares approved for issuance (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Increase In Shares Approved For Issuance
Share-based Compensation Arrangement by Share-based Payment Award, Increase In Shares Approved For Issuance
Disclosure of detailed information about intangible assets
Disclosure of detailed information about intangible assets [text block]
Value at issuance
Value at Issuance
Value at Issuance
Entity Addresses, Address Type [Axis]
Entity Addresses, Address Type [Axis]
Percentage of reasonably possible decrease in unobservable input, liabilities
Percentage of reasonably possible decrease in unobservable input, liabilities
Investments held at fair value
Disclosure Of Investments held at fair value [Text Block]
Disclosure Of Investments held at fair value
Issuance of new preferred shares – financing cash flow
Issue of equity
Adjustments to reconcile net income/(loss) to net cash used in operating activities:
Adjustments to reconcile profit (loss) [abstract]
Auditor Firm ID
Auditor Firm ID
Long-term loan
Disclosure of borrowings [text block]
Document Transition Report
Document Transition Report
Local Phone Number
Local Phone Number
Preferred shares
Subsidiary preferred shares
Beginning balance
Ending balance
Preferred Share Liability
Preferred Share Liability
Balance at beginning of period
Balance at end of period
Total Lease Liability
Total Lease Liability
Lease liabilities
Available indefinitely
Available indefinitely [Member]
Available indefinitely
Realized loss on sale of investments
Adjustments for losses (gains) on disposal of non-current assets
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Operating Segments
Description of accounting policy for segment reporting [text block]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Disclosure of interests in Subsidiaries [Table]
Ranges
Ranges [member]
Total equity
Equity at beginning of period
Equity at end of period
Equity
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards [Line Items]
Directors and Senior Managers Shareholdings and Share Incentive awards
Oxford Finance LLC
Oxford Finance LLC [Member]
Oxford Finance LLC
Loans
Loans [Member]
Loans
Alivio Therapeutics, Inc.
Alivio
Alivio [Member]
Alivio
Disclosure of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Schedule of summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations [Table Text Block]
Schedule of summary of aggregation of subsidiaries with material non-controlling interests before intra-group eliminations
Exercise of share-based awards
Increase (decrease) through exercise of options, equity
Borrowing From PureTech Health
Borrowing From PureTech Health [Member]
Borrowing From PureTech Health
Non-adjusting events after reporting period
Non-adjusting events after reporting period [member]
Auditors Remuneration [Table]
Auditors Remuneration [Table]
Auditors Remuneration
Reclassification of foreign currency differences on dilution of interest
Other comprehensive income, before tax, gains (losses) from investments in equity instruments
Consolidated Statements of Financial Position
Statement of financial position [abstract]
Address Type [Domain]
Address Type [Domain]
Finance income/(costs) – fair value accounting
Finance income costs - fair value accounting, reconciliation of effective tax rate
Finance income costs - fair value accounting, reconciliation of effective tax rate
Senior Managers
Senior Managers [Member]
Senior Managers
Weighted average ordinary shares and adjusted weighted average ordinary shares [abstract]
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Disclosure of weighted average exercise prices for options exercisable
Disclosure of Weighted Average Exercise Prices for Options Exercisable [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Exercisable
Document Fiscal Period Focus
Document Fiscal Period Focus
Disclosure of convertible notes
Schedule of Convertible Notes [Table Text Block]
Schedule of Convertible Notes
Knode Inc. (indirectly held through Enlight)
Knode
Knode [Member]
Knode
Disclosure of subsidiary notes payable
Schedule of Notes Payable [Table Text Block]
Schedule of Notes Payable
Akili
Akili [Member]
Akili
Accounting policies, changes in accounting estimates and errors [Abstract]
Accounting Policies [Abstract]
Accounting Policies
Subsidiary preferred shares
Issued capital, preference shares
Dr Joseph Bolen
Dr Joseph Bolen [Member]
Dr Joseph Bolen
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Construction in progress
Construction in progress [member]
3.00 to 4.00
Exercise Price Range Four [Member]
Exercise Price Range Four [Member]
Licenses
Licences [member]
Additions, net of transfers
Additions other than through business combinations, property, plant and equipment
Short-term investments
Short-term investments
Short-term Investments
Short-term Investments
Receipt of payment of sublease
Receipt of payment of sublease
Receipt of payment of sublease
Borrowings by name [axis]
Borrowings by name [axis]
Disclosure of changes in financial liabilities, level 3 fair value - subsidiary preferred shares and convertible notes
Disclosure Of changes in Financial Liabilities, level 3 fair value - Subsidiary Preferred Shares and Convertible Notes [Table Text Block]
Disclosure Of changes in Financial Liabilities, level 3 fair value - Subsidiary Preferred Shares and Convertible Notes
Range of Exercise Prices (in GBP per share)
Exercise price range (in dollars per share)
Exercise price of outstanding share options
Disclosure of weighted average exercise prices for options forfeited
Disclosure of Weighted Average Exercise Prices for Options Forfeited [Table Text Block]
Disclosure of Weighted Average Exercise Prices for Options Forfeited
Share premium
Share premium
Effect of dilutive shares (in shares)
Dilutive effect of share options on number of ordinary shares
Deferred tax liabilities, net, recognized
Net deferred tax liabilities
Trade payables
Current trade payables
Share of associate loss allocated to long-term interest (see Note 6)
Share of associate loss allocated to long-term interest
Share of associate loss allocated to long-term interest
Financial Assets
Description of accounting policy for financial assets [text block]
Finance income
Total finance income
Finance income
Accrued interest on convertible notes - finance costs
Accrued interest, Convertible Notes
Accrued interest, Convertible Notes
Convertible note, percentage of equity price trigger
Debt Instrument, Convertible, Percentage Of Equity Price Trigger
Debt Instrument, Convertible, Percentage Of Equity Price Trigger
Balance at end of period after allocation of associate loss to long-term interest
Financial Assets At Fair Value Through Profit Or Loss after allocation to long-term interest
Financial Assets At Fair Value Through Profit Or Loss after allocation to long-term interest
Ownership interest
Ownership Interest
Ownership Interest
Earnings/(Loss) attributable to owners of the Company [Table]
Earnings/(Loss) attributable to owners of the Company [Table]
Earnings/(Loss) attributable to owners of the Company
Weighted Average
Weighted average [member]
Undiscounted lease receivable
Undiscounted finance lease payments to be received
Number of business days following the consummation of a qualified financing
Current Receivables Due From Associates, Term, Number Of Business Days Following The Consummation Of A Qualified Financing
Current Receivables Due From Associates, Term, Number Of Business Days Following The Consummation Of A Qualified Financing
Changes in the value of subsidiary preferred shares [Abstract]
Changes in the value of subsidiary preferred shares [Abstract]
Changes in the value of subsidiary preferred shares
Range [axis]
Range [axis]
Related party transactions [Line Items]
Related party transactions [Line Items]
Related party transactions
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Proceeds from issue of convertible notes
Trade and other payables
Adjustments for increase (decrease) in trade accounts payable
Ms Dapne Zohar
Ms Dapne Zohar [Member]
Ms Dapne Zohar
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Deferred Tax Assets and Liabilities [Table]
Entity Current Reporting Status
Entity Current Reporting Status
Investment in Sonde Preferred shares – Sonde deconsolidation
Financial Investments, Gain (Loss) Recognised Through Profit (Loss) When Control Of Subsidiary Is Lost
Financial Investments, Gain (Loss) Recognised Through Profit (Loss) When Control Of Subsidiary Is Lost
Disclosure of maturity analysis of finance lease payments receivable [table]
Disclosure of maturity analysis of finance lease payments receivable [table]
Dr John LaMattina
Dr John LaMattina [Member]
Dr John LaMattina
Disclosure of unrecognized tax losses and tax credits carryforwards
Disclosure of unrecognized tax losses and tax credits, deferred tax assets [Table Text Block]
Disclosure of unrecognized tax losses and tax credits, deferred tax assets
Non-current liabilities
Non-current liabilities [abstract]
SPAC exchange, PIPE transaction, amount
SPAC Exchange, PIPE Transaction, Amount
SPAC Exchange, PIPE Transaction, Amount
Gain on deconsolidation of subsidiary
Gain on deconsolidation
Gains (losses) recognised when control of subsidiary is lost
Voting percentage through the holdings
Proportion of voting rights held in subsidiary
Level 3 of fair value hierarchy
Level 3 of fair value hierarchy [member]
Financial liabilities
Financial liabilities
Excess of fair value at reclassification date over grant date fair value
Excess of fair value at reclassification date over grant date fair value
Excess of fair value at reclassification date over grant date fair value
Gain/(loss) on investment held at fair value
Gain/(Loss) on changes in fair value
Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets
Operating income/(loss)
Profit (loss) from operating activities
Other
Other tax rate effects for reconciliation between accounting profit and tax expense (income)
Gains (losses) on earn-out shares at fair value through profit or loss
Gains (Losses) On Earn-out Shares At Fair Value Through Profit Or Loss
Gains (Losses) On Earn-out Shares At Fair Value Through Profit Or Loss
Valuation techniques used in fair value measurement [axis]
Valuation techniques used in fair value measurement [axis]
RSU [Table]
RSU [Table]
RSU
Federal
Federal [Member]
Federal
Business combination, investment in common share
SPAC Exchange, Backstop Agreement, Investment In Common Share
SPAC Exchange, Backstop Agreement, Investment In Common Share
Business combination, number of additional shares received at no additional cost (in shares)
Business Combination, Number Of Additional Shares Received At No Additional Cost
Business Combination, Number Of Additional Shares Received At No Additional Cost
Proportion of ownership interest in investee
Proportion of ownership interest in investee
Proportion of ownership interest in investee
Interest
Interest On Undiscounted Lease payments
Interest On Undiscounted Lease payments
NCI exercise of share options in subsidiaries
Increase Decrease Through NCI exercise of share-based awards in Subsidiaries
Increase Decrease Through NCI exercise of share-based awards in Subsidiaries
Follica, Incorporated
Follica
Follica [Member]
Follica
Contributed By - Types [Axis]
Contributed By - Types [Axis]
Contributed By - Types
Disclosure of financial liabilities [table]
Disclosure of financial liabilities [table]
Intangible Assets
Description of accounting policy for intangible assets other than goodwill [text block]
Grant revenue
Income from government grants
Convertible debt, instruments, converted to equity
Convertible Debt, Instruments, Converted To Equity
Convertible Debt, Instruments, Converted To Equity
Transaction Costs
Rate of transaction costs, reconciliation of effective tax rate
Rate of transaction costs, reconciliation of effective tax rate
Gains (losses) on change in fair value of derivatives
Gains (losses) on change in fair value of derivatives
Segment Information
Disclosure of entity's operating segments [text block]
Purchase of treasury stock
Payment To Purchase Treasury Stock
Payment To Purchase Treasury Stock
Parent company and other
Parent Company And Other [Member]
Parent Company And Other
Share-based awards expiration period
Share-based Compensation Arrangement By Share-based Payment Award, Expiration Period
Share-based Compensation Arrangement By Share-based Payment Award, Expiration Period
Undiscounted lease maturities
Undiscounted operating lease payments to be received
Disclosure of associates [table]
Disclosure of associates [table]
Taxation [Abstract]
Taxation [Abstract]
Taxation [Abstract]
Liabilities
Liabilities [abstract]
Additional number of shares authorized to purchase
Additional number of shares authorized to purchase
Additional number of shares authorized to purchase
Business combination, additional shares to be received at no additional cost, transaction cost
Business Combination, Additional Shares To Be Received At No Additional Cost, Transaction Price
Business Combination, Additional Shares To Be Received At No Additional Cost, Transaction Price
Equity
Equity [member]
Fair Value Measurements
Description of accounting policy for fair value measurement [text block]
Purchases of short-term investments
Purchase of financial instruments, classified as investing activities
Audit-related assurance services
Audit related assurance services
Audit related assurance services
Disclosure of finance income (cost)
Disclosure of finance income (cost) [text block]
Subsidiary warrant liability
Warrants [Member]
Subsidiary warrant liability [Member]
Subsidiary warrant liability
Recognition of deferred tax assets and tax benefits not previously recognized
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Deferred tax assets and benefits not previously recognised, reconciliation of effective tax rate
Comprehensive income/(loss) attributable to:
Total comprehensive income/(loss) attributable to:
Comprehensive income attributable to [abstract]
Exercise price (in dollars per share)
Exercise price
Exercise price
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Percentage vote and value of subsidiaries in the Group consolidated state tax return
Earnings/(Loss) attributable to owners of the Company [Line Items]
Earnings/(Loss) attributable to owners of the Company [Line Items]
Earnings/(Loss) attributable to owners of the Company
Short-term note [Table]
Short-term note [Table]
Short-term note [Table]
Trade and Other Payables
Disclosure of trade and other payables [text block]
Settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Increase decrease through settlement of restricted stock units
Number of shares issued by investee (in shares)
Number of shares issued by investee
Number of shares issued by investee
More than five years
Later than five years [member]
Business Or Sourcing Company [Axis]
Business Or Sourcing Company [Axis]
Business Or Sourcing Company
Disclosure of subsidiaries
Disclosure of subsidiaries [text block]
Other
Other inflows (outflows) of cash, classified as operating activities
Depreciation of tangible assets
Depreciation expense
Depreciation expense
Equity-accounted associate – share of other comprehensive income (loss)
Gains (losses) on exchange differences on translation of foreign operations, before tax
Current portion of long-term loan
Current portion of non-current borrowings
Number of common shares redeemable from each RSU (in shares)
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Common Shares Redeemed Per Restricted Share Unit
Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Common Shares Redeemed Per Restricted Share Unit
Equity price risk
Equity price risk [member]
Other current financial liabilities
Other current financial liabilities
Discount, conversion from notes - qualified financing
Discount, conversion from notes - qualified financing
Discount, conversion from notes - qualified financing
Share of losses recorded against Long Term Interests (LTIs)
Share of associate loss recorded against long-term interest
Share of associate loss recorded against long-term interest
Aggregate principal amount
Notional amount
Risks [member]
Risks [member]
Sale of royalty interest
Sale Of Royalty Interest [Member]
Sale Of Royalty Interest
Weighted Average Options exercisable [Line Items]
Weighted Average Options exercisable [Line Items]
Weighted Average Options exercisable
Contributed By
Contributed By [Member]
Contributed By
Lease liability, initial term
Lease Liability, Initial Term
Lease Liability, Initial Term
Investments held at fair value [Abstract]
Investments held at fair value [Abstract]
Tal Medical, Inc.
Tal [Member]
Tal
Reconciliation of average effective tax rate and applicable tax rate [abstract]
Weighted average remaining contractual life of outstanding share options (in years)
Weighted average remaining contractual life of outstanding share options
Internal
Internal [Member]
Internal
Share of net loss of associates accounted for using the equity method
Share of net loss of associates accounted for using the equity method
Share in net loss of associates
Share of profit (loss) of associates and joint ventures accounted for using equity method
Interest income on loans and receivables
Interest income on loans and receivables
Disclosure of significant unobservable inputs, level 3 fair value - preferred shares liability
Financial Instruments, Significant Unobservable inputs, level 3 fair value - Preferred Shares liability [Table Text Block]
Financial Instruments, Significant Unobservable inputs, level 3 fair value - Preferred Shares liability
Total Subsidiary Types
Total Subsidiary Types [Member]
Total Subsidiary Types
Estimated Time to Exit
Estimated time to exit, measurement input [Member]
Estimated time to exit, measurement input
Classes of financial assets [axis]
Classes of financial assets [axis]
Entity's total for subsidiaries
Entity's total for subsidiaries [member]
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue [Table]
Disaggregation of Revenue - Customers over 10% of revenue
Disclosure of detailed information about borrowings
Disclosure of detailed information about borrowings [text block]
Auditor Location
Auditor Location
Entity Filer Category
Entity Filer Category
Share in other comprehensive loss of associates
Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax
Proceeds from maturity of short-term investments
Proceeds from sales or maturity of financial instruments, classified as investing activities
UNITED STATES
UNITED STATES
Sonde Health, Inc.
Sonde
Sonde [Member]
Sonde
Endra Holdings, LLC (held indirectly through Enlight)
Endra Holdings LLC [Member]
Endra Holdings LLC
Performance share plan
Performance Share Plan [Member]
Performance Share Plan
Assets
Assets [abstract]
Percentage ownership interest
Proportion of ownership interest in associate
Nontrading holding companies
Nontrading holding companies [Abstract]
Nontrading holding companies
Security Exchange Name
Security Exchange Name
Disposals
Disposals, property, plant and equipment
Directors and Senior Managers Shareholdings and Share Incentive awards [Abstract]
Directors and Senior Managers Shareholdings and Share Incentive awards [Abstract]
Directors and Senior Managers Shareholdings and Share Incentive awards
Convertible note receivable
Convertible Note Receivable [Member]
Convertible Note Receivable
Financial Instruments
Description of accounting policy for financial instruments [text block]
Finance costs – contractual
Total finance cost – contractual
Finance costs
Unused federal orphan drug tax credits
Unused Federal orphan drug tax credits
Unused Federal orphan drug tax credits
Issued share capital acquired (in shares)
Issued Share capital acquired
Issued Share capital acquired
Reversal of equity method losses recorded against LTIs (due to decrease in LTI fair value)
Reversal of equity method losses recorded against LTIs (due to decrease in LTI fair value)
Reversal Of Investment Loss In Associates Accounted For Using Equity Method
Reversal Of Investment Loss In Associates Accounted For Using Equity Method
Subsidiary Preferred Shares Balances [Table]
Subsidiary Preferred Shares Balances [Table]
Subsidiary Preferred Shares Balances [Table]
Disclosure of trade and other payables
Schedule of Trade And Other Payables [Table Text Block]
Schedule of Trade And Other Payables
Disclosure of liquidity risk
Disclosure of liquidity risk [text block]
Temporary difference, unused tax losses and unused tax credits
Temporary difference, unused tax losses and unused tax credits [member]
Short-term Investments
Short-Term Investments [Member]
Short-Term Investments
Cover [Abstract]
Preferred
Preference shares [member]
Entity Voluntary Filers
Entity Voluntary Filers
Purchase of property, plant and equipment against trade and other payables
Purchase of property plant and equipment against trade and other payables
Purchase of property plant and equipment against trade and other payables
Non-audit related services
Auditor's remuneration for other services
Classes of intangible assets other than goodwill [axis]
Classes of intangible assets other than goodwill [axis]
Short-term note from associate
Short-term note from associate [Member]
Short-term note from associate
IFRS 15, Revenue from Contracts with Customers
Description of accounting policy for recognition of revenue [text block]
Executive Compensation
Rate of executive compensation, reconciliation of effective tax rate
Rate of executive compensation, reconciliation of effective tax rate
Number of shares in entity held by entity or by its subsidiaries or associates (in shares)
Number of shares in entity held by entity or by its subsidiaries or associates
Impairment
Description of accounting policy for impairment of non-financial assets [text block]
Subsidiary:
Subsidiary [Abstract]
Subsidiary
Liabilities from share based payment transactions, performance and market conditions met
Liabilities From Share based Payment Transactions, performance and market conditions met
Liabilities From Share based Payment Transactions, performance and market conditions met
Balance of accreted premium net of unamortized issuance costs
Borrowings, Discount [Member]
Borrowings, Discount
Long-term loan
Beginning balance
Ending balance
Total Long-term loan
Borrowings
Subsidiary Plans [Line Items]
Subsidiary Plans [Line Items]
Subsidiary Plans
Sensitivity range, increase
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Period
Sensitivity Analysis For Types Of Market Risk, Reasonably Possible Increase In Risk Variable, Period
Subsidiary Notes Payable
Disclosure of Subsidiary Notes Payable [Text Block]
Disclosure of Subsidiary Notes Payable
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Investment in Associates [Abstract]
Series D
Series D [Member]
Series D
Share capital
Issued capital
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management [Line Items]
Capital And Financial Risk Management
Issuance of warrants in subsidiary
Issuance of warrants
Issuance of warrants
Associates [axis]
Associates [axis]
Disclosure of operating segments
Disclosure of operating segments [text block]
Components of equity [axis]
Components of equity [axis]
Contract Balances [Table]
Contract Balances [Table]
Contract Balances [Table]
Sale of investments held at fair value
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
Retained earnings/ (accumulated deficit)
Retained earnings [member]
Subsidiary Types [Axis]
Subsidiary Types [Axis]
Subsidiary Types
Contact Personnel Name
Contact Personnel Name
Weighted average grant date fair value, RSU granted (in GBP per share)
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Weighted average grant date fair value of other equity instruments granted in share-based payment arrangement
Recognised Income Tax Expense [Abstract]
Recognised Income Tax Expense [Abstract]
Recognised Income Tax Expense
Equity and liabilities
Equity and liabilities [abstract]
Functional and Presentation Currency
Description of accounting policy for functional currency [text block]
Trade and other payables
Total trade and other payables
Trade and other current payables
Transaction Costs
Transaction Costs, reconciliation of effective tax rate
Transaction Costs, reconciliation of effective tax rate
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
Trade and other receivables
Current trade receivables
Associates
Associates [member]
Merger reserve
Merger reserve
General and administrative expenses
General and administrative expenses
General and administrative expenses
General and administrative expense
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Tax losses and tax credits carryforwards [Table]
Gelesis Earn out shares received in SPAC exchange
Financial Investments, Fair Value Of Earnout Shares Received From SPAC Exchange
Financial Investments, Fair Value Of Earnout Shares Received From SPAC Exchange
Bottom of range
Bottom of range [member]
Entity Address, Address Line Two
Entity Address, Address Line Two
Entity Address, Address Line One
Entity Address, Address Line One
Accounting Policies
Disclosure of significant accounting policies [text block]
Gain on dilution of ownership interest in associate
Gain on dilution of ownership interest in associate
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate
Gain (Loss) Recognized On Dilution Of Ownership Interest In Associate
Other non-current assets
Other non-current assets
Other
Borrowings, other
Borrowings, other
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares [Roll Forward]
Changes in the value of subsidiary preferred shares
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Subsidiary Notes Payable - Loans [Table]
Income tax receivable – current
Trade receivables, income tax receivable
Trade receivables, income tax receivable
Borrowings by name
Borrowings by name [member]
Issuance of long term loan
Proceeds from non-current borrowings
Disclosure of revenue
Disclosure of revenue from contracts with customers [text block]
Salaries and wages
Wages and salaries
Disclosure of subsidiary preferred share balances
Summary of Subsidiary Preferred Shares Balances [Table Text Block]
Summary of Subsidiary Preferred Shares Balances
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities
Disclosure of sensitivity analysis of fair value measurement to changes in unobservable inputs, liabilities [text block]
Non controlling interests and options issued to third parties
Non controlling interests and options issued to third parties
Non controlling interests and options issued to third parties
Other income/(expense)
Other operating income (expense)
Income/(Loss) for the year
Net income/(loss)
Income/(loss) for the year
Profit (loss)
Preferred share warrants
Preferred share warrants [Member]
Preferred share warrants
Customers over 10% of revenue
Major customers [axis]
Major customers [axis]
Notes Payable [Line Items]
Notes Payable [Line Items]
Notes Payable
Interest paid
Interest paid, classified as operating activities
Sonde Deconsolidation
Deconsolidation adjustments, reconciliation of effective tax rate
Deconsolidation adjustments, reconciliation of effective tax rate
Diluted earnings/ (loss) per share (in dollars per share)
Diluted earnings (loss) per share
Consideration paid (received)
Consideration paid (received)
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]
Disclosure of significant unobservable inputs used in fair value measurement of liabilities [table]
Subsidiary Plans [Abstract]
Subsidiary Plans [Abstract]
Subsidiary Plans
Rental income
Rental income
Interest Expense
Interest expense, reconciliation of effective tax rate
Interest expense, reconciliation of effective tax rate
Earnings/(loss) per share
Earnings/(loss) per share [Abstract]
Earnings/(loss) per share
Total share-based payments expense category
Total Share-based Payments Expense Category [Member]
Total Share-based Payments Expense Category
Share capital
Share capital [member]
Equity
Disclosure of Equity [Text Block]
Disclosure of Equity
Cash flows from operating activities
Cash flows from (used in) operating activities [abstract]
Short-term and Long-term of lease receivables [Table]
Short-term and Long-term of lease receivables [Table]
Short-term and Long-term of lease receivables [Table]
Common
Ordinary shares [member]
Other reserve
Other reserves [member]
Performance Share Plan [Line Items]
Performance Share Plan [Line Items]
Performance Share Plan
Taxation
Income tax expense/(benefit)
Income tax expense/(benefit)
Income tax expense/(benefit)
Tax expense (income)
Disclosure of Maturity Analysis of Operating Lease Payments [Table]
Disclosure of maturity analysis of operating lease payments [table]
Percentage of reasonably possible increase in unobservable input, liabilities
Percentage of reasonably possible increase in unobservable input, liabilities
Maturity [axis]
Maturity [axis]
Prepaid expenses for expected subsidiary IPO, audit related assurance services
Prepaid expenses for expected subsidiary IPO, Audit related assurance services
Prepaid expenses for expected subsidiary IPO, Audit related assurance services
Disclosure of directors’ and senior managers’ shareholdings and share incentive awards
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory [Table Text Block]
Disclosure Of Information About Shareholdings of Key Management Personnel Explanatory
Additions
Additions Lease Liabilities
Additions Lease Liabilities
Share-based payment arrangements
Share-based payment arrangements [member]
Right of use asset, net
Balance at beginning of period
Balance at end of period
Right-of-use assets
Aggregated time bands
Aggregated time bands [member]
Expected dividend yield
Expected dividend, share options granted
Provisions
Description of accounting policy for provisions [text block]
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Percentage vote and value of subsidiaries included in the Group consolidated federal tax return
Finance income [Abstract]
Finance income [Abstract]
Finance income
Performance obligations [axis]
Performance obligations [axis]
Accounts receivable
Receivables from contracts with customers
Summary of financial information of Gelesis
Summary of Financial information of Gelesis [Table Text Block]
Summary of Financial information of Gelesis
Equity
Equity [abstract]
Stock incentive plan
Stock Incentive Plan [Member]
Stock Incentive Plan
Issuance of subsidiary preferred Shares
Proceeds from issue of preference shares
Total assets
Total assets
Assets
Income tax payable
Trade and Other Payables
Trade payables, income tax payable
Trade payables, income tax payable
Accumulated depreciation and impairment loss
Accumulated depreciation, amortisation and impairment [member]
Other income/(expense):
Other income/(expense) [Abstract]
Other income/(expense)
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Financial Instruments - Fair value Measurement and Classification [Table]
Gain (loss) on derivative assets recognized through profit or loss
Gain (Loss) On Derivative Assets Recognized Through Profit Or Loss
Gain (Loss) On Derivative Assets Recognized Through Profit Or Loss
Deductible Temporary Difference
Deductible temporary differences for which no deferred tax asset is recognised
Disclosure of short-term and long-term portion of lease liability
Disclosure of short-term and long-term portion of lease liability [Table Text Block]
Disclosure of short-term and long-term portion of lease liability
Finance Cost Net [Abstract]
Finance Cost Net [Abstract]
Reclassifications
Increase (decrease) through transfers from construction in progress, property, plant and equipment
Disclosure of short-term and long-term portion of lease receivable
Disclosure of short-term and long-term portion of lease receivable [Table Text Block]
Disclosure of short-term and long-term portion of lease receivable
Development Costs
Description of accounting policy for research and development expense [text block]
Disclosure of financial liabilities [abstract]
Net investment in the lease
Net investment in finance lease